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CHAPTER I 
INTRODUCTION 
BACKGROUND OF INTEGRIN 
The vertebrate vascular network is a closed system that functions to 
circulate nutrients, oxygen, and immune cells to all tissues in the body and to 
transport metabolites. According to the WHO, cardiovascular disease is a major 
cause of death worldwide [1]. As one of the major constituents of blood vessel 
walls, vascular smooth muscle cells (VSMCs) are responsible for the 
maintenance of vessel structure and function. VSMCs are surrounded by 
basement membranes that consist of a large number of extracellular matrix 
(ECM) proteins, which facilitate normal nutrition and metabolisms of arterial 
VSMCs [2]. ECM contains a variable proportion of a large variety of matrix and 
non-matrix proteins, providing a mechanical framework, facilitating intercellular 
communication, and promoting wound healing [3-5]. Extracellular matrices are 
composed of fibrous proteins (collagens and elastin) embedded in a gel-like 
polysaccharide ground substance (glycosaminoglycans and proteogylcans) 
and adhesion proteins that link components of the matrix both to one another 
and to attached cells (fibronectin, laminin and entactin) [6]. ECM composition 
notably influences its mechanical properties and is variably expressed 
throughout the vascular hierarchical network [7, 8]. In large arteries, ECM is 
composed of elastin which is arranged in fenestrated sheets or lamelle into a 
three-dimensional continuous network between collagen fibers and thin layers 
of proteoglycan-rich ECM, while arterioles contain endothelial cells and VSMCs 
with less elastin and collagen [9]. Though currently there is little known about 
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the nanoscale organization of the ECM and how it is regulated in the vascular 
wall, EMC composition is known to be regulated through synthesis and 
degradation, which is reported to change in pathological conditions [10, 11]. For 
example, hypertension is associated with increased arterial stiffness 
characterized by fissuring and fracturing of elastin and collagen proliferation [8].  
The ECM is physically linked with cells through transmembrane proteins 
called integrins, which connect the ECM to the cell cytoskeleton. Integrin 
proteins are heterodimers formed by the non-covalent association of two 
subunits, designated  and . In the vascular system, VSMCs have been 
reported to express 13 of the approximately 24 known integrins: 11, 21, 
31, 41, 51, 61, 71, 81, 91, v1, v3, v5, and 64. A large 
number of studies from our laboratory have shown integrin involvement in 
controlling vascular functions, which has been well addressed in reviews by 
Martinez-Lemus [13, 14]. Adhesion of integrin to extracellular matrix is a highly 
dynamic process, which is well addressed in Figure 1-1 [15]. Integrins are 
expressed and remain in a low-affinity binding state until cellular stimulation 
activates and transforms them into a high-affinity form. One important 
mechanism for regulating integrin function is through tight spatial and temporal 
control of integrin affinity for extracellular ligands, which is achieved by rapid, 
reversible changes in the conformation of the extracellular domains of the 
integrin heterodimers, termed ‘integrin activation’ [16]. This affinity-dependent 
mechanism combines with additional affinity-independent mechanisms (such 
as integrin clustering, lateral diffusion of receptors, interactions with and 
reorganization of the cytoskeleton, and changes in integrin expression patterns) 
to control integrin-mediated adhesion [16-19]. Changes in integrin activation 
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are reported in angiogenesis and altered regulation of integrin activation is 
evident during impaired cardiac function, suggesting the importance of integrin-
mediated cell adhesion in a variety of normal and pathological conditions [20, 
21]. In VSMCs changes in integrin expression and adhesion have both been 
associated with vascular diseases [22-24]. VSMCs, like all tissues in the body, 
are subjected to dynamic stimuli from the surrounding microenvironment or 
cells themselves, indicating integrin-mediated VSMCs attachment to ECM is 
also undergoing dynamic regulation. However, the importance of dynamic 
behavior is not completely understood in VSMCs and additional research is 
needed for better understanding vasculature and providing possible 
pathological targets.  
 
Figure 1-1. Dynamics of focal adhesion formation. In resting state, integrins are 
present on VSMCs in an inactive ‘bent’ conformation. Upon outside-in cell 
signaling there is recruitment of talin to the membrane that binds to the integrin 
tail and makes integrin to adopt an extended conformation that has high affinity 
for specific ECM protein ligands. After binding to ECM ligands, the integrin 
connects to actin filaments through activation of vinculin to promote formation 
of a nascent focal complex that matures into a focal adhesion. Maturation 
involves clustering of integrins and recruitment of additional cytoskeletal focal 
adhesion proteins. Focal adhesion turnover also occurs and is regulated by 
disassembly of the actin cytoskeleton and loss of interaction of vinculin with 
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PIP2. Source: Lacolley, P., et al., Vascular Smooth Muscle Cells and Arterial 
Stiffening: Relevance in Development, Aging, and Disease. Physiol Rev, 2017. 
97(4): p. 1555-1617.[15] 
 
VASCULAR STIFFNESS 
 Arterial stiffness, as one of the earliest detectable manifestations of 
adverse structure and functional changes within the vessel wall, increases with 
advancing age and is an independent predictor of cardiovascular morbidity and 
mortality [25, 26]. The elastic properties of the arterial wall material depend not 
only on the vascular cells, including ECs and VSMCs, but also ECM and how 
these components are spatially organized [27]. The methodology for measuring 
arterial stiffness depends on the size of the artery and its location along the 
arterial tree. Due to the incompressibility of the blood and the distensibility of 
the arteries, the pulse generated by the heart travels at finite wave speed along 
the arterial network. By measuring the pulse wave velocity (PWV), it can be 
used as good indicator for measurement of vascular stiffness. According to the 
Moens-Korteweg equation, the PWV is related to the square root of the 
elasticity modulus. The elastic modulus increases in stiffer arteries as does the 
PWV. Clinically, carotid-femoral pulse wave velocity is used as the gold 
standard for the measurement of aortic stiffness [28]. Based on this technique, 
it has been shown PWV practically doubles form a value of ~5 m/s at the age 
of 20 to over 10 m/s at the age of 80, which implies that distensibility of the 
aorta is reduced by 4 over that age range [29]. Recently, improved techniques 
based on PWV broaden utility of this methods, such as combined with magnetic 
resonance imaging. However, techniques for measuring stiffness in smaller 
vessels are much less developed and study of the biomechanical properties of 
small arteries relies on ex vivo techniques such as isolated vessels, vessel rings 
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and vessel strips [15]. Although changes in vascular stiffness are largely 
believed to be due to changes in the composition and organization of the ECM 
[9], VSMCs have also been shown to stiffen with age and hypertension [30, 31]. 
Thus, the VSMC itself can contribute to overall changes in the vascular wall 
with stiffening. In addition, VSMC contractile tone also stiffens the artery wall.  
The changes in VSMC stiffness are intriguing and it remains an important 
question to determine whether the cellular changes occur in response to the 
stiffening of the ECM or whether the cellular changes in stiffness precede the 
ECM changes. To address this complex question more studies are needed of 
the longitudinal development or time course of vascular stiffening. In addition, 
mathematical models of the integrin interactions that occur with the ECM could 
provide valuable insight useful in designing appropriate biological experiments. 
One of the important goals of the research in this dissertation was to use a 
mathematical model to predict integrin adhesion behavior in response to 
pulsatile changes in stretch applied to integrin-ECM adhesions.  
CYTOSKELETON IN VSMCS 
The cytoskeleton in VSMCs, like all eukaryotic cells, is composed of 
three principal types of protein filaments: actin filaments, intermediate 
filaments, and microtubules, which are held together and linked to subcellular 
organelles and the plasma membrane by variety of accessory proteins [32]. In 
addition to serving as a scaffold for providing cellular structural framework, the 
cytoskeleton is also responsible for internal transportation of organelles and 
proteins. Importantly, the cytoskeleton is a dynamic structure that is continually 
reorganized as cells grow, move and change shape. 
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Actin is the major cytoskeletal protein in cells, and it exists in both a 
soluble monomeric form (G actin) and a polymeric filamentous state (F actin) 
[32]. The soluble free cytosolic actin monomers are constantly exchanging with 
actin monomers within the actin filaments. In VSMCs, actin filaments are 
anchored to the membrane via a complex of adhesion proteins via integrins, 
cadherins and at cytosolic dense bodies that are composed primarily of the 
actin cross-linking protein, -actinin [33]. During actin filament assembly two 
patterns of filament formation are observed.  One is formation of branching 
structures and the other involves changes in filament length such as elongation. 
Remodeling of the actin network is a constant feature of this cytoskeletal 
component and it is facilitated by actin depolymerization and debranching both 
of which facilitate dynamic remodeling. In contractile VSMCs, stress fibers are 
also assembled and act as contractile/structural bundles containing actin 
filaments and myosin II [34]. In addition to well established actomyosin 
interaction that leads to contraction, dynamic remodeling of the actin 
cytoskeleton is also recognized as an important step in the agonist-induced 
activation of contraction and tension development [33, 35]. Actin dynamics can 
be regulated by multiple actin-associated proteins and many intracellular 
signaling pathways. RhoA has been reported to promote actin nucleation and 
stress fiber assembly by activating mammalian Diaphanous-related formins 
(mDia) [36]. LIM kinase is another target of RhoA/RhoK pathway, which 
phosphorylates cofilin, leading to actin polymerization [37, 38]. 
Intermediate filaments (IFs) are also widely distributed in the cytoplasm, 
and type III IF proteins vimentin and desmin are major components of the IF 
network in smooth muscle [39].  VSMCs mainly express vimentin, which is 
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widely distributed in various blood vessels ranging from elastic arteries to 
arterioles in the microcirculation while desmin is not or very little detected in 
large arteries such as aorta, but mainly present in arterioles [39, 40]. 
Traditionally, IFs are considered not directly involved in cell movements, but 
rather they appear to play a structural role by providing mechanical strength to 
cells and tissues [32]. However, recent studies suggest IF network is an 
essential component for force development in smooth muscle and that 
contractile activation induces partial disassembly of vimentin and/or desmin 
filaments, and spatial rearrangement of vimentin to modulate force 
development through the redistribution of signaling molecules [41]. 
Microtubules are long and hollow cylinders made up of - and -tubulin 
dimers, which bind in a head-to-tail manner into protofilaments that associate 
laterally to from hollow tubes [32]. They are essential for cell shape and variety 
of cell movements, including cell division and the intracellular transport of 
organelles and vesicles. It has been shown that microtubules regulate focal 
complex assembly/disassembly, protrusion and cell contraction locally [40]. In 
arterioles, microtubule depolymerization induces an increase in RhoA activity 
and causes constriction [42]. In VSMCs, it is also reported that microtubule 
stabilization attenuates cell calcification [43].  
CONTRACTILE ACTIVATION PATHWAYS IN VSMCS 
VSMCs display considerable plasticity in phenotype such that in healthy 
blood vessels mostly exhibit the contractile phenotype but switch frequently 
switch to a synthetic, largely non-contractile phenotype in cardiovascular 
diseases [44]. The synthetic phenotype being dominated by proliferative and 
migratory characteristics. Contractility of VSMCs is key to its principle function 
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related to regulating vascular resistance which determines arterial blood 
pressure. The ability of VSMC to contract and regulate vascular caliber results 
from the contractile filaments composed of actin and myosin which undergo 
complex molecular interactions that allow the VSMC to shorten thereby 
affecting vascular radius. According to Poiseulle’s law blood flow and pressure 
are sensitive to the radius to the fourth power making adjustments in vascular 
diameter a powerful way to regulate blood flow and pressure. In VSMC, actin 
and myosin filaments are gathered into loose bundles unlike the highly structure 
arrays of actin and myosin found in skeletal and cardiac muscle [34]. These 
bundles are anchored to dense bodies in the cytosol and to attachment plaques 
at cell membrane. Myosin II, is a major molecular motor present in muscle cells, 
consisting of two identical heavy chains (MHC) and two pairs of light chains 
(MLC). Myosin bind to actin filaments in a reversible fashion allowing the 
myosin to move along the actin filaments creating a sliding of actin filaments 
relative to each other. This interaction generates contraction by hydrolyzing 
ATP. Phosphorylation of 20-kDa MLC has been identified as an essential event 
for actomyosin interaction [34]. This is controlled by Ca2+ and Rho kinase 
signaling pathways. Intracellular Ca2+ can be increased either from extracellular 
Ca2+ influx through opening of voltage-gated Ca2+ channels or release from 
intracellular stores via sarcoplasmic reticulum. Opening of stores occurs via 
activation of G protein-coupled receptors and subsequent inositol triphosphate 
(IP3) productions. MLC has been known to be phosphorylated at Ser19 
mediated by Ca2+/calmodulin-activated myosin light chain kinase (MLCK), 
which in turn promote actomyosin interaction and contraction [34, 44]. VSMCs 
is highly spatially organized with respect to its organelles and signaling 
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pathways. This compartmentalization regulates Ca2+ signals that regulate 
contractility as well as other intracellular functions in a more selective manner. 
MLC could also be regulated by dephosphorylation which is Ca2+ independent. 
This regulation is mediated by a specific type 1 myosin light chain phosphatase, 
MLCP, which is a heterotrimer consisting of a catalytic subunit and a regulatory 
subunit, known as myosin phosphatase target subunit (MYPT1). Activation of 
Rho-family small GTPase with their downstream effectors (Rho-associated 
protein kinase, RhoK) activates phosphatase MYPT1, that inhibits MLCP 
activity [45]. Activation of PKC and/or RhoA/RhoK signaling pathway thus 
results in Ca2+ sensitization of contractile proteins and thereby tonic VSMC 
contraction despite decreased levels of intracellular Ca2+ [46].   
ANGIOTENSIN II SIGNALING IN VSMCS 
Angiotensin II (AII) is an important hormone regulated by the renin-
angiotensin system. It is a powerful vasoconstrictor and regulates VSMC 
function via binding to its cell-surface receptors AT1R and AT2R, which belong 
to the G proteins coupled seven trans-membrane superfamily [47]. In vessels, 
the AT2R has been reported less localized on the VSMCs but is mainly 
expressed in adventitial cell types [48]. AT1R is the major receptor that 
mediates most of the physiological and pathophysiological effects of AII, 
including vasoconstriction, inflammation, growth, and fibrosis [49]. It is 
suggested that AT2R may counteract many of the AT1R-mediated actions. 
When AII binds to the Gq/G11 coupled AT1R it results in activation of many 
intracellular signaling pathways, including PLC, Ca2+ channels, MAP kinases, 
NADH oxidase and others as well as alterations in gene expression leading to 
changes in protein expression within the cell [50].  
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AII-induced contraction in VSMCs is mediated by both Ca2+ dependent 
and Ca2+ independent pathways [51]. It is well established that AII binding to 
AT1R activates PLC isoforms to generate second messenger, IP3 and DAG. 
IP3 in turn is well known to induce calcium release from sarcoplasmic reticulum 
via the ryanodine receptor (RyR). Voltage-dependent calcium channels are 
also reported to be activated directly or indirectly by AII. DAG mediates VSMCs 
contraction through activation of protein kinase C (PKC), which in turn 
phosphorylates MLCK leading to activation of several other target proteins 
promoting contraction [52].  
The MAPKs have also been implicated in AII induced VSMC 
proliferation, hypertrophy and differentiation [53]. The extracellular signal-
regulated kinase 1 and 2 (ERK1/2), the c-Jun N-terminal kinase (JNK), p38 
MAPK, and big MAPK1 (BMK1 OR ERK5) have all been identified to play an 
important role in these functions [54, 55]. The ERK1/2 pathway exerts a 
hypertensive action induced by AII through triggering MLCK and thereby MLC 
phosphorylation. AII has been known to induce phosphorylation of multiple 
tyrosine kinases, including c-Src, janus family kinase (JAK), focal adhesion 
kinase (FAK), Pyk2, p130Cas and phosphatidylinositol 3-kinase (PI3K). 
Activation of RhoA/Rho-kinases signaling also has been reported in AII-
stimulated VSMCs [56-58]. 
As a potent stimulator of vascular NAD(P)H oxidase, AII mediates many 
of its effects by stimulating production of reactive oxygen species (ROS) [59, 
60]. Of the many types of ROS generated, superoxide anion (•O2-), hydrogen 
peroxide (H2O2), nitric oxide (NO) and peroxynitrite (ONOO-) are particularly 
important in the cardiovascular system. It’s reported that AII induces activation 
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of the enzyme NAD(P)H oxidase as well as increase expression of its subunits. 
It also stimulates ROS production in cultured VSMCs and intact arteries. ROS 
influences many intracellular signaling such as MAP kinase, tyrosine kinases 
and protein phosphatase while upstream signaling molecules including PLD, 
PKC, c-Src, PI3K and Rac [61]. Thus, AII signaling in VSMC is extremely 
intricate involving many potential pathways either directly or indirectly. It ability 
to initiate Ca2+ signaling was an important focus of the research presented in 
this dissertation.  
RATIONALE 
The mechanical properties of VSMC is determined by the cytoskeleton, 
that is resulted from both dynamic actomyosin interactions as well as by the 
capacity of the actin cytoskeleton to rapidly depolymerize and reploymerize [30, 
31, 62]. Furthermore, VSMC mechanics have been shown to be dependent on 
cell-matrix adhesion [63-65] and recent evidence from our laboratory showed 
that integrin adhesion is coordinated with VSMCs stiffness, which can be 
rapidly up-regulated with contraction and downregulated during relaxation in 
response to vasoactive agents [66]. However, the mechanisms governing 
dynamic response to agonists have not been completely understood.  
Therefore, the first project of this research focused on possible 
mechanisms governing this dynamic behavior of adhesion in response to 
agonists and changes in VSMC stiffness. Studies of the myogenic response in 
resistance vessels reveal an overlap between calcium signaling and integrin-
signaling pathways in VSMC [13, 67]. Ligands of the 51 and 41 integrin 
produce significant enhancement of L-type calcium current while ligands of the 
v3 integrin cause a decrease in VSMC([Ca2+]i [68-70].  Collectively, these 
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data implicate a role of integrin in intracellular calcium ([Ca2+]i). In project one, 
we hypothesized that the coordination of cell stiffness and cell adhesion to FN 
of VSMCs was mediated by changes [Ca2+]i. To address this hypothesis, 
calcium indicator fluo-4 was used to measure [Ca2+]i simultaneously with real-
time monitoring cell stiffness and adhesion to ECM protein fibronectin (FN). In 
this study, we found that cell stiffness and cell adhesion to FN are changed 
directionally with [Ca2+]i.  
Project two of this work focused on how integrin adhesion is influenced 
by dynamic mechanical stimulation. VSMCs from elastic arteries and smaller 
resistance arteries are exposed to mechanical stretch stress or tension [9, 71]. 
This cyclic strain stress is created by the pulse pressure. This oscillating stretch 
is felt by VSMCs through their interaction with ECM mediated by integrins, and 
can be dissected to contain stretching in both the lateral and vertical directions. 
In this project, we collaborated with applied mathematical scientists from the 
University of Nottingham to test a simulation model of integrin adhesion 
behavior to oscillations. They proposed a 3-spring model to investigate the 
interaction of integrin and ECM during dynamic stretching of the integrin-ECM 
adhesion. The model predicted that integrin adhesion outcomes are dependent 
on initial integrin adhesion and applied oscillation amplitudes. We 
experimentally verified the dependence of integrin adhesion on these 
parameters.  
AFM APPLIED TO MEASURING CELL MECHANICS AND 
ADHESION 
My research was largely dependent on using atomic force microscopy 
(AFM). The invention of AFM opened a new area of research that can directly 
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stimulate cells with local nanoscale forces [72, 73]. By probing biological 
structures, AFM can obtain images over a large range of length scales such as 
DNA, proteins, and cellular surface structure with nanometer resolution [74-76]. 
For imaging, a soft cantilever with a very small tip at the end scanned across 
the surface of a sample.  A laser beam is aligned to the end of the cantilever, 
which is precisely moved in the xy-direction with a piezoelectric scanner. The 
cantilever bends in response to surface topography during scanning, thus 
reconstructing movement of the reflected laser beam would get topographic 
images of biological structures.  
Apart from imaging, AFM force spectroscopy can be used to quantify the 
mechanical properties and interactions of biological systems over scales form 
cells to single-molecules [77-79]. In force spectroscopy, AFM cantilever can be 
moved perpendicular to the cell surface and treated as a spring to get force 
acted on cantilever by Hooke’s law with its spring constant at resolution of pN. 
In this work, cell mechanics and adhesion were measured by ‘force-distance 
curves’ that are recorded by the deflection of the cantilever movement as it 
approaches to and retracts from a cell surface. During the approach, the 
cantilever will begin bending upward as it is pushed on the sample, after 
determining the contact point, the recorded force-distance curve can be 
converted into force-indentation curve. The cell modulus can be obtained by 
fitting the force-indentation curve with Hertz model [77].  
AFM can also be applied to probe molecular interactions, which enables 
the measurement of the strength of the interaction forces between the probe 
and cells [80, 81]. Labelling the tip with chemical groups or bio-ligands will allow 
AFM a unique opportunity to probe the properties of specific ligand-receptor 
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complexes [82]. For retraction force curves, AFM tip is retracted while also 
measuring the force acting on the cantilever. If a molecular interaction exists, 
the cantilever will bend downwards until the interacting pair of molecules 
rupture, which produces rupture events. The height of the rupture event 
corresponds to the force required to break a single molecule interaction, thus 
to the binding strength of a given receptor. Therefore, AFM-based single cell 
force spectroscopy is capable of revealing the mechanical and energetic 
characteristic of single receptor-ligand interactions on the surfaces of living 
cells. Moreover, spatially resolved force-distance curves can provide a means 
to localize individual molecules on the cell surface. Additionally, these 
approaches have also been adapted to measure the mechanical interaction 
between a single cell and other cells [83].   
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CHAPTER II 
MECHANISMS COORDINATING VASCULAR SMOOTH 
MUSCLE ADHESION TO THE EXTRACELLULAR 
MATRIX DURING CONTRACTION 
ABSTRACT 
Physical coupling of vascular smooth muscle cells (VSMCs) to 
extracellular matrix proteins (ECM) by integrins is required for efficient 
mechanotransduction. Integrin adhesion receptors are essential for normal 
vascular function and defective integrin signaling is associated with 
cardiovascular disease. There is a large body of accumulated literature on 
integrin activation in cancer cells and leukocytes, but far less is known about 
mechanism of integrin activation in VSMCs as it relates to vasoregulation. 
Previous work from our laboratory demonstrated that increased VSMC 
stiffness, induced by the vasoconstrictor Angiotensin II (AII), is coordinated with 
enhanced adhesion to fibronectin (FN) indicating an important role for adhesion 
in contraction. However, the mechanism of this coordination is not fully 
understood. In this study, we hypothesized that enhanced adhesion in 
response to AII was mediated by integrin activation through an inside-out 
signaling pathway linked to increases in intracellular Ca2+ ([Ca2+]i). By using 
atomic force microscopy (AFM) with an anti-5 antibody coated AFM probe, we 
confirmed that cell stiffness was increased by AII, but we observed no changes 
in adhesion to the anti-5 antibody. This indicated that increases in cell 
adhesion to FN induced by AII was occurring through an integrin activation 
process, as increased membrane integrin expression/receptor density would 
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have been accompanied by increased adhesion to the anti-5 antibody. Further 
studies with KCl and BAPTA-AM were used to modulate the level of [Ca2+]i. 
After KCl, VSMCs showed a rapid transient increase in cell stiffness as well as 
cell adhesion to FN, and these two events were synchronized with 
superimposed transient increases in the level of [Ca2+]i, which was measured 
using the Ca2+ indicator, fluo-4. These changes were not abolished in VSMCs 
pretreated with the myosin light chain kinase inhibitor, ML-7. In contrast, 
VSMCs incubated with intracellular calcium chelator, BAPTA-AM, showed 
reductions in stiffness and cell adhesion to FN as well as decreased [Ca2+]i. 
These data suggest that in VSMCs integrin activation is regulated by levels of 
[Ca2+]i and is not dependent on events downstream of contraction. These 
findings provide additional evidence to support a role for adhesion in VSMC 
contraction and suggest that following cell contractile activation, that adhesion 
may be regulated in tandem or even in advance of the contractile event.  
INTRODUCTION 
Normal cardiovascular function depends on the biomechanical 
properties of blood vessels, and changes in these properties are characteristic 
of diseases including hypertension, stroke, aneurysms, atherosclerosis and 
heart disease [84]. The mechanical properties of a blood vessel are determined 
by its components and their organization. Accordingly, the stiffness of vascular 
tissue can be derived from the composition of the extracellular matrix (ECM) 
and the cells in the tissue, the organization of the matrix and cells, and the 
connections that link these components (cell-matrix and cell-cell contacts) [85]. 
It is commonly accepted that changes in the ECM predominately mediate 
vascular stiffness, that decreased elastin and increased collagen have been 
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identified as the most altered ECM components [7, 10]. In addition to the ECM, 
it has been recently established that vascular smooth muscle cells (VSMCs), 
as the main cellular constituent of the vascular wall, are also recognized to be 
associated with reduced flexibility and increased stiffness of the blood vessel 
wall. For example, Sehgel et al. [30] found increased elastic stiffness of VSMCs 
in spontaneously hypertensive rats, and Zhu et al. [31] have demonstrated 
higher stiffness in VSMCs from old monkeys than young monkeys. Cytoskeletal 
proteins, and contractile states have been proved to mediate cell stiffness in 
VSMCs [62, 66, 86]. In these studies, VSMC adhesion to ECM proteins was 
also shown to be enhanced as well as cell stiffness. Fibronectin (FN) is one of 
the major ECM proteins that promotes adhesion of VSMCs to ECM by binding 
to integrin receptors through functional specialized domains such as arginine-
glycine-aspartate (RGD sequence), reported to accumulate in diseased artery 
walls [87]. Of importance, the 51 integrin is recognized as a major FN receptor 
and plays an important role in VSMCs mechanoreception linking it to vascular 
regulation [88, 89]. 
Integrins, as heterodimeric membrane receptors composed of two 
noncovalent associated transmembrane subunits –and -, provide an 
important physical connection between the ECM and the cytoskeleton, 
maintaining a dynamic adhesion between the cell and its microenvironment. 
This unique feature of integrins make them ideally situated for bi-directionally 
transmitting mechanical forces and the generation of cell signals through both 
inside-out and outside-in mechanisms. Integrins are known to regulate cell 
differentiation, proliferation, and survival through controlling critical intracellular 
signals [90-92]. Accumulated evidence has demonstrated that an important role 
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for integrins in regulating vascular function [93-95]. Among the multitude of 
integrin receptors identified on the surface of VSMCs, integrin 51 acts as the 
dominant FN receptor [87, 88, 96]. In previous work from our laboratory, Hong 
et al. demonstrated the existence of coordination between cell stiffness and cell 
adhesion of VSMCs to FN as they respond to the contractile vasoactive agonist 
Angiotensin II (AII) or to the vasodilators adenosine and nitric oxide [66, 97]. 
This coordination of adhesion with the contractile state was suggested to be 
regulated by changes in integrin behavior [66]. The function of integrin can be 
controlled by both ‘outside-in’ signaling and ‘inside-out signaling’ [98]. In the 
case of VSMC activation by soluble vasoactive agonists it is likely that changes 
in the integrin activation state are occurring through an ‘inside-out activation’ 
process from within the cell. Such changes in integrin activation occur through 
conformational changes in the extracellular integrin head domains in which they 
can switch reversibly from a low-affinity conformation to a high-affinity active 
conformation [16]. Integrin 51 has been observed to undergo conformational 
changes in focal adhesions [99], and these changes have been demonstrated 
to occur with alterations in cytoskeletal tension [100, 101]. However, the 
mechanism underlying the changes in integrin activation in VSMCs in response 
to vasoactive-agonists is not fully understood.  
In this study, we hypothesized that the coordination of cell stiffness and 
cell adhesion to FN of VSMCs is mediated by changes in intracellular calcium 
([Ca2+]i). Therefore, the enhanced adhesion in response to AII may result from 
integrin activation through an ‘inside-out’ signaling pathway linked to an 
increase in [Ca2+]i. To address this hypothesis, we utilized atomic force 
microscopy (AFM) combined with confocal microscopy. AFM has the ability to 
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detect and apply mechanical forces at the nano- and pico-newton ranges, 
providing  a powerful tool for investigating biomechanical properties of VSMCs 
[102] and for measuring changes in cell adhesion molecules [73, 101, 103]. In 
this study, AFM was used for real-time monitoring of cell stiffness and adhesion. 
This allowed us to analyze these variables in the time domain and correlate 
them with [Ca2+]i, measured using the calcium indicator fluo-4. We show that 
cell stiffness and cell adhesion to FN are changed directionally with [Ca2+]i. We 
also observed that increased cell stiffness and adhesion to FN was not 
abolished by preventing contractile filament interaction via inhibiting myosin 
light chain kinase (MLCK). Thus, the changes in cell stiffness and adhesion 
appear to occur by a signaling pathway parallel to but not downstream of 
contraction.  
METHODS 
Reagents and Materials applied 
For all studies described, human plasma fibronectin (FN), 1, 2-bis(o-
aminophenoxy) ethane-N, N, N’, N’-tetraacetic acid (acetoxymethyl ester) 
(BAPTA-AM), and fluo 4-AM were purchased from Invitrogen (Carlsbad, CA, 
USA), Bovine Serum Albumin (BSA), KCl, AII were purchase from Sigma (St. 
Louis, MO, USA). Antibodies to -actin, integrin 5, Angiotensin II type I 
receptor (AT1R) and phalloidin 647were purchased form Abcam (Cambridge, 
UK).  For all cell isolations, dithioerythriotol (Dith), papain, collagenase, 
soybean trypsin inhibitor, and elastase were purchased from Sigma (St. Louis, 
MO, USA).  For studies using atomic force microscopy (AFM), a Bioscope II 
AFM system (Bruker, Santa Barbara, CA, USA) was mounted on an Fluoview 
confocal microscope (Olympus, Thornwood, NY). AFM data were collected and 
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analyzed using Nanoscope (Bruker, Santa Barbara, CA, USA) and Matlab 
(MathWorks, Natick, MA, USA) software. Confocal images were analyzed by 
using ImagePro Plus software (Media Cybernetics, Carlsbad, CA). 
Cell preparation 
Animal and Tissue preparation 
Male Sprague-Dawley rats (200 g-300 g) were used in this study and 
were maintained in accordance with the protocol of the Guide for the Care and 
Use of Laboratory Animals (NIH 83-23, revised 1996). The animal protocol was 
reviewed and approved by the Laboratory Animal Use Committee (ACUC) of 
the University of Missouri. Animals were housed individually in a 12:12 light- 
dark cycle with free access to food and water. Arteriole were isolated as 
descripted in previous work with minor modification [66]. Briefly, rats were 
anesthetized by intraperitoneal injection of pentobarbital sodium (Lundbeck, 
Inc., Deerfield, IL, USA) at 0.1 g/kg. A surgical plane of anesthesia was 
confirmed by observing no spinal reflex to a toe pinch. The cremaster muscle 
was removed through a scrotal surgical incision while rats remained under 
anesthesia, and the tissue was immediately placed in cold (4 oC), Ringer’s 
buffer (composed of 145 NaCl mM, 4.7 KCl mM, 2.0 CaCl2-2H20 mM, 1.0 
MgSO4-7H20 mM, 1.2 NaH2PO4-H2O mM, 0.02 EDTA-2H2O mM, 3.0 MOPS, 5 
Glucose mM, 2.0 Pyruvic Acid mM). Vessels and cell isolations were performed 
in solution based on Ringer’s buffer. Anesthetized rats were euthanized by 
intracardial injection of saturated KCl solution (3 ml).  The cremaster muscles 
were then pinned flat onto a silicone rubber pad in a bath of cold Ringer’s buffer. 
With the aid of a stereomicroscope (Olympus SZX10, Thorwood, NY, USA), 
long segments of the first and second order cremasteric feed arterioles vessel 
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were dissected and isolated from surrounding skeletal muscle tissue. The 
isolated arteriole segments were removed and cut into small pieces (~2-3 mm) 
and were placed into culture dishes (35 mm) with Ringer’s buffer in room 
temperature, and subsequently processed to isolate vascular smooth muscle 
cells (VSMCs).  
VSMCs isolation and culture 
VSMCs were enzymatically isolated using previously described methods 
[104].  Briefly, arteriolar segments were transferred to a glass culture tube (10 
mm  75 mm) that contained 1 ml of the first cell dissociation solution that 
Ringer’s buffer included 27 U/ml of papain and 1 mg/ml dithioerythriotol. The 
segments were incubated at 37 oC for 30 minutes without agitation. At the end 
of this interval, the first cell dissociation solution was carefully decanted and 
replaced with 1 ml of second cell dissociation solution consisting of Ringer’s 
buffer and 0.5 U/ml collagenase, 75 U/ml elastase, and 1 mg/ml soybean 
trypsin inhibitor. The segments were further incubated for 12-15 minutes at 
37oC. At the end of the incubation period, the dissociation solution was carefully 
decanted with that not disturb the arteriole segment. Arteriole segments were 
then very carefully and gently washed twice by adding 1ml Ringer’s buffer, 
followed by 1 ml serum-free supplemented Dulbecco’s modified Eagle’s 
medium (DMEM)/F12 (Invitrogen, Carlsbad, CA, USA). The vessels segments 
were pipetted with a glass pipet (1 ml) for about 20-30 times to disperse 
individual cells from the tissue. The solution containing the dispersed VSMCs 
was then decanted into 60 mm tissue culture dishes (Corning incorporated, 
Corning, NY, USA), and maintained under culture conditions in a humidified 
incubator with 5% CO2, at 37 oC, in DMEM supplemented with 20% fetal bovine 
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serum (FBS, ATLANTA Biologicals, Laurenceville, GA, USA), 10 mM HEPES 
(Sigma, St. Louis, MO, USA), 1 mM sodium pyruvate, 2 mM L-glutamine, 100 
U/ml penicillin, and 100 g/ml streptomycin. After 48 hours’ incubation, the 
culture medium was changed to DMEM with 10% FBS.  The cells used in all 
experiments were maintained under these conditions for 5-10 days without 
passage. Prior to an experiment the VSMCs were serum starved overnight.  
Force spectroscopy measurement 
Bio-functionalized AFM probes  
A 5m diameter glass bead (Structure Probe Inc., West Chester, PA, 
USA) was glued on the tip of an AFM probe (MLCT-O10, Bruker Corp., Santa 
Barbara, CA, USA) and then coated with FN or anti-5 antibody using the 
protocol previously used in our Laboratory [88]. Briefly, the bead was first glued 
on a clean AFM probe and then FN was attached to bead by a cross-linker. 
Before gluing the glass bead to the cantilever tip, each cantilever was calibrated 
before a given experiment using thermal noise amplitude analysis. Cantilevers 
were then cleaned first by rinsing in 100% ethanol twice followed by rinsing in 
acetone for 3 times. The cantilever was dipped in glue (Progressive Epoxy 
Polymers Inc., USA) and then brought into contact with a glass bead mixture in 
solution that had been smeared on a glass slide. After bead attachment, AFM 
probes were stored for 48 hours to allow bead glue to cure. The AFM probe 
with attached bead was then processed to bio-coat the bead tip. Polyethylene 
glycol (PEG, Sigma, St. Louis, MO) was used as cross-linker for attachment of 
proteins of interest to the bead.  The tip was first incubated with 10mM PEG for 
5 minutes, followed by washing four times with distilled water, and then 
incubated with FN (0.25 mg/ml) or anti-5 antibody (1 mg/ml) for 5 minutes, 
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followed by rinsing four times with Phosphate-Buffered Saline (PBS) (1.05 mM 
KH2P04, 155.17 mM NaCl, 2.96 mM Na2HP04-7H20).  For all experiments, the 
AFM spring constants were assumed to be unchanged after protein labeling.  
Nano-indentation protocol of AFM 
Monitoring of biomechanical properties of single live VSMCs in real time 
was performed using a Bioscope II AFM system (Bruker, Santa Barbara, CA, 
USA) that was mounted on an IX81 OLYMPUS inverted microscope (Olympus 
Inc., NY, USA) (Fig. 2-1). All AFM measurements were conducted at room 
temperature in a 1% HEPES supplemented DMEM without antibiotics. The FN-
coated spherical probe (Fig. 2-1D) was used to repeatedly indent and retract 
from the cell surface at 0.1Hz sampling frequency, 1000 nm ramp size. For 
each experiment, cells were randomly selected and indented at a site midway 
between the nucleus and cell margin. 60 force curves were collected over 10 
minutes for a pre-drug period followed by 240 force curves over 40 minutes for 
the post-drug condition. To minimize the machine drift, after the probe was 
initially submerged in the cell bath, the AFM-microscope system was thermally 
and mechanically equilibrated for 1 hour. The analysis of force curves was 
processed by a custom analysis program written in MATLAB. 
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Figure 2-1. AFM system and AFM probe. (A) A Bioscope AFM system (Bruker, 
Corp. Santa Barbara, CA, USA) was mounted on a Fluoview confocal 
microscioe (Olympus, Thornwood, NY). (B) An AFM chip with 5 different 
probes. (C) An AFM probe used for contact mode scanning images and force 
volume images. (D) Spherical bead bond AFM probe used for measuring cell 
adhesion and cell stiffness. 
 
Measurement of biomechanical properties with AFM 
The stiffness measured with the nano-indentation protocol is an estimate 
of Young’s modulus of elasticity (E-modulus) for the cell cortex, reflecting the 
cell’s viscoelastic properties. A length of approximately 100-300nm of the AFM 
indentation curve, following the initial point of contact was fitted to a modified 
Hertz Model, which was used to assess the VSMC elasticity (Fig. 2-2B) 
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Here, F is the force exerted by the AFM probe on the cell surface; E is the E-
modulus;  is Poisson ratio (assumed as 0.5); r is radius of spherical AFM tip; 
 is indentation depth into the cell membrane. Rupture force, also referred to 
here as adhesion force between FN and integrin adhesion complexes, was 
determined from the retraction curves as the product of the rupture height and 
cantilever spring constant (Fig. 2-2C).  
AFM contact mode imaging  
To obtain a topographical cell image, the AFM tip was brought into 
contact with the cell surface and was placed in scanning mode to move it 
horizontally along the cell surface while applying a constant force (500 – 800 
pN) to the cell. Scanned images were 100 m  100 m at digital density of 512 
pixels  512 pixels. A stylus-type AFM probe (Fig. 2-1B, model MLCT-C,  = 
15pN nm-1, Bruker, Santa Barbara, CA, USA) was used to perform the cell 
surface scanning at 0.15 Hz frequency at room temperature. Height and 
deflection image were collected with Bioscope software and analyzed using 
Nanoscope software.  
AFM force volume imaging 
Force volume was conducted to measure overall cell stiffness, scanning 
100 m  100 m at digital density of 128 pixels  128 pixels. For each pixel, a 
stylus-type AFM probe was used to repeatedly indent and retract following 
previous nano-indentaion protocol at 0.1Hz. Deflection images were collected 
by Bioscope software and used to generate modulus image using Nanoscope 
software. 
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Figure 2-2. Illustration of the protocol used in an AFM experiment. (A) The FN 
coated AFM probe was cyclically interact with the VSMC membrane. The 
approach curve (blue) was fitted to Hertz model and used to estimate cell 
elasticity (B). (C) The adhesion data was collected from retraction curve. 
Adhesion was quantified as the number of ruptures that were counted as 
individual adhesion events and by adhesion force that was calculated by 
rupture height multiplied by cantilever spring constant. 
 
Measurement of intracellular Calcium  
Fluo-4 AM loading of VSMCs 
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Intracellular calcium was measured by imaging fluo-4 AM. Cells cultured 
on glass-bottomed tissue culture dishes (Corning incorporated, Corning, NY, 
USA) were washed with loading buffer (150 mM NaCl, 5 mM KCl, 1 mM MgCl, 
10 mM glucose, and 20 mM HEPES, pH 7.4) twice and then incubated with 2.5 
mM fluo 4-AM (Invitrogen Corp., Carlsbad, CA) in loading buffer (150 mM NaCl, 
5 mM KCl, 1 mM MgCl, 10 mM glucose, and 20 mM HEPES, pH 7.4) 
supplemented with 2% BSA and 0.01 % Pluronic F-127 (BASF) for 25 minutes 
at room temperature on a rolling plate.  Cells were then washed with loading 
buffer twice and then incubated at 30oC in serum free DMEM for 20 minutes to 
allow the de-esterification.  
BAPTA-AM Loading of VSMCs 
Cells cultured on glass-bottomed tissue culture dishes were washed 
twice with loading buffer (150 mM NaCl, 5 mM KCl, 1 mM MgCl, 10mM glucose, 
and 20 mM HEPES, pH 7.4) and then incubated with 2.5 mM BAPTA-AM 
(Invitrogen, Carlsbad, CA) in loading buffer supplemented with 2% BSA and 
0.01 % Pluronic F-127 (BASF) for 25 minutes at room temperature on a rolling 
plate agitator. Cells were then washed with loading buffer twice and then 
incubated at 30oC in serum free DMEM for 20 minutes to allow the de-
esterification.  
Fluorescence imaging 
To assess the correlation between cell stiffness and adhesion with 
intracellular calcium levels, we performed calcium imaging and made AFM 
measurements simultaneously. Calcium fluorescence images were collected 
continuously, starting at 20 seconds before the AFM pulling was applied, and 
ended 20 seconds after the pulling. Fluo-4-loaded VSMCs were visualized 
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using a confocal microscope (FV1000) equipped with a 488 nm laser, and the 
signal was collected at 510~550 nm ×60 oil immersion objective used for all 
imaging experiments. Fluo-4 images were analyzed using Fluoview software.  
Cell staining for fluorescence immunocytochemistry and confocal 
microscopy 
Prior to immunocytochemistry, VSMCs were serum-starved overnight. 
After treatment under different conditions (AII treated at 10-6M for 30 minutes 
versus PBS exposure for 30 minutes, as a control), cells were washed with PBS 
three times followed by fixation with 2% paraformaldehyde for 30 minutes at 
room temperature. Cells were then quenched with glycine buffer (0.1mM 
glycine) three times for 10 minutes. After being washed, cells were incubated 
with primary antibody (1:100 dilution in labeling buffer: 150mM NaCl, 15mM 
Na3C6H5O7, 0.05% Triton X-100, 2% BSA) overnight at 4oC. Cells were then 
washed six times with cold washing buffer (150mM NaCl, 15mM Na3C6H5O7, 
0.05% Triton X-100), followed by incubation with Cy5-labeled secondary 
antibody (1:200 dilution in labeling buffer) and Alex 488-conjugated phalloidin 
(1:200 dilution in labeling buffer) for 2 hours at room temperature in a dark 
environment on a rolling plate. The cells were washed again by cold washing 
buffer and imaged with a confocal microscope using excitation wavelengths of 
647nm and 488nm, respectively. A through-focus image set was collected for 
each cell with a z step interval of 0.2m.  
Statistical analysis 
All data are reported as mean ± SEM. Statistical differences for 
comparisons of pre-drug controls and post-drug treatments were analyzed with 
paired t-test. ANOVA was used for between group analysis. All statistical 
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analyses were performed using open source software SCIDAVIS and StatPlus 
(AnalystSoft Inc., CA, USA). Differences were considered significant at P  ≤
 0.05. 
RESULTS 
Vascular Smooth Muscle Cell Characteristics 
VSMCs were immuno-labeled for -actin (anti--actin (red)) and stained 
with phalloidin (green), which is a widely accepted molecular marker for VSMC 
[105] in order to confirm the cells’ identity. VSMCs exhibited the typical spindle-
shaped morphology and displayed typical stress fibers visible after immuno-
labeling (Fig. 2-3). Additional topology imaging of the VSMCs was performed 
using the AFM to obtain contact-mode deflection images of the VSMCs. 
Topology images revealed large, mostly parallel bands of cytoskeletal filaments 
(stress fibers) underlying the cell membrane surface (Fig. 2-3G). The topology 
images also showed the cell nucleus as the highest point of the cell above the 
culture substrate. The AFM was also used in force volume mode to measure 
stiffness at numerous randomly selected sites on the cell surface (Fig. 2-3E and 
F). The stiffness measurements showed that the nucleus had the lowest 
modulus of elasticity whereas the non-nuclear areas displayed higher elastic 
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modulus. 
 
Figure 2-3. Images of cultured VSMCs. (A-D) Immunostaining of VSMCs with 
and -actin (B and D, red) and staining of phalloidin (A and C, green). Cells 
exhibited spindle-shaped morphology and displayed numerous actin filaments 
and stress fibers (E and F). AFM images acquired in force volume mode 
showed softest site (lowest stiffness) on the cell surface and highest location 
was over the nucleus. Contact scanning images of deflection error (G) and cell 
height (H) on single cultured VSMC. 
 
Force curves for analysis of FN-VSMC adhesion force 
To measure the adhesion force between FN and cell surface integrins, 
FN-coated probes were applied to the surface of VSMC at randomly selected 
locations midway between the nucleus and cell margin (Fig. 2-4D). Two typical 
force curves are shown in Fig. 2-4. The blue trace line depicts the approach 
curve and the red trace line represents the retraction curve with the force plotted 
as a function of probe position. As the probe approaches the cell (point 1 to 
point 2), force remains at zero level. At the point that the probe contacts the cell 
surface (point 2), a resistance is encountered and a force increase is detected 
as the AFM cantilever is deflected. As indentation depth increases, the 
resistance force increases (point 2 to point 3) until the probe stops approaching 
and begins to retract. During probe retraction (red trace), the resistance force 
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declines (point 3 to point 4). In cases when there is no adhesion between FN 
and VSMC, the retraction curve resembles and overlays the approach curve 
(Fig. 2-4A). In contrast, if adhesions exist between the FN-coated AFM probe 
and the VSMC surface (Fig. 2-4B), pulling force increases during the retraction 
corresponding to adhesion strength and cantilever deflection is reversed. When 
the retraction force exceeds the strength of the adhesion, an abrupt force shift 
(point 5) is observed in the retraction curve, representing rupture of the 
adhesion between the AFM probe and cell. When all adhesions between the 
AFM probe and VSMC have been ruptured, the retraction curve again 
resembles the approach curve (point 6). 
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Figure 2-4. Typical force curves generated by AFM. (A) Retraction curve 
showing no adhesion between the AFM probe and the cell surface. (B) 
Retraction curve showing adhesion ruptures between the AFM probe and 
the cell surface. (C) A schematic of the AFM probe movement during the 
process of force curve generation. AFM fibronectin (FN)-coated probes were 
controlled to repeated approach and retract from VSMC surface at 0.1-Hz 
frequency. (D) Image of spherical AFM probe on VSMC. 
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Figure 2-5. AII increased VSMCs stiffness but had no effect on cell adhesion to 
anti-5 antibody. Group average real-time recordings of cell stiffness (blue 
square), rupture events (green triangle), and rupture force (purple cross) for AII 
(n=8) treatment (A) and addition of PBS (n=10) (E). Average elastic modulus 
summed across all or 15 minutes of time points for the group of VSMCs before 
and after AII (10-6 M) treatment (B) (n=8, *P < 0.05) and PBS addition (F) (n=10, 
*P < 0.05). Average rupture numbers per curve summed across all or 15 
minutes of time points for the group of VSMCs before and after addition of AII 
(C) (n=8, *P < 0.05) and PBS (G) (n=10, *P < 0.05). (D) Average rupture force 
summed across all or 15 minutes of time points for the group of VSMCs before 
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and after addition of AII (D) (n=8, *P < 0.05) and PBS (H) (n=10, *P<0.05). Data 
were collected at 0.1 Hz of indentation frequency and are presented as mean 
 SEM. 
 
Membrane expression of integrin 5 following angiotensin II (AII) 
treatment 
Previous work in our laboratory has shown that AII increases VSMCs 
stiffness as well as adhesion to FN [62, 66]. Specificity of FN binding to 51-
integrin on VSMCs was confirmed by demonstrating that adhesion was 
inhibited with function blocking antibodies to 5 or 1 integrins [88]. To determine 
whether the increased cell adhesion during AII treatment was due to enhanced 
membrane expression of integrin 51, we used AFM probes coated with anti-
5 antibody. We hypothesized that if AII was increasing the number of 5 
integrins on the cell surface, then adhesion to the antibody-coated probes 
would increase.  In these experiments, 8 cells were treated with AII and of these 
5 responded with the characteristic increase in cell stiffness whereas 3 of the 
cells did not respond.  Only responsive cells were analyzed. The increase in 
cell stiffness (blue circle) was gradual after AII exposure and reached a plateau 
after approximately 15 minutes, which is consistent with previous reports from 
our laboratory (Fig. 2-5A). Before treatment, average cell stiffness was 6.04  
0.26 kPa, and which increased to 7.47  0.21 kPa after AII representing a 
statistically significant increase by 24% (Fig. 2-5B). As a control, VSMCs were 
treated with PBS which showed no effect on cell stiffness (Fig. 2-5E and F).  
Cell adhesion was analyzed in the AII responsive cells and was 
quantified as the number of ruptures per curve (Fig. 2-5A, green triangles) and 
the total rupture force (Fig. 2-5A, purple crosses). After AII treatment, cell 
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adhesion to anti-5 antibody, measured as rupture number per curve (Fig. 2-
5C), was not significantly increased. In addition, rupture force showed no 
observable increase with AII (Fig. 2-5D). PBS-treated cells also showed no 
effect on average rupture number per curve or total rupture force (Fig. 2-5E, G, 
and H).  
 
 
Figure 2-6. AII has no effect on expression of integrin 5 in VSMCs. (A-D) 
Immunostaining of integrin 5 (red) and labeling with phalloidin (green) on 
VSMCs before treatment (A), after addition of AII (10-6 M) (B) and PBS (C). (D) 
is negative control without anti-integrin 5 as primary antibody. (E) 
Immunostaining of nucleus (blue), Angiotensin II Type I receptor (ATIR, green), 
and phalloidin (red). Scale bars represent 10 m. 
 
 As a further test to confirm a lack of change in expression of integrin 5, 
we also performed immunostaining of 5 on VSMCs. Cells were co-labelled 
with phalloidin to visualize cell stress fibers. Immunofluorescence confocal 
microscopy showed that 5 integrin was diffusely distributed on the apical 
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surface of VSMCs (Fig. 2-6A). After treatment with AII, there were no 
observable changes of 5 distribution on the cell surface or intensity of labelling 
(Fig. 2-6B). As control group, PBS treatment also had no effect on 5 
distribution or labelling intensity (Fig. 2-6C). In Fig. 2-6E, immunostaining of 
angiotensin receptor subtype 1 (AT1R) (green) was also performed on VSMCs 
together with phalloidin (red). ATIR shows widely distributed on apical surface 
of cells. Collectively, these data suggest that AII-induced increases in VSMCs 
adhesion to FN does not result from enhanced membrane expression of 
integrin 5. Rather, these data are consistent with an effect of AII to increase 
integrin activation. 
Effect of KCl treatment on VSMC stiffness and adhesion to FN  
AII is known to act on the AT1R and to cause increases in intracellular 
Ca2+ ([Ca2+]i) in VSMCs [106, 107]. To test the hypothesis that [Ca2+]i was 
playing a role in the enhanced adhesion to FN and increase in cell stiffness we 
utilized KCl (60mM). KCl is a non-receptor agonist which increases levels of 
[Ca2+]i secondary to cell depolarization. In these experiments, FN (0.25mg/ml) 
coated AFM probes were used to measure cell stiffness and adhesion response 
to KCl. Before treatment, average cell stiffness was 7.64  1.65 kPa, and 
application of KCl induced a rapid transient and significant increase in cell 
stiffness to 18.87  4.39 kPa (Fig. 2-7A, blue circle) representing a 142% 
increase (Fig. 2-7B, blue square) (Fig. 2-7C). During the period when cell 
stiffness was transiently elevated we observed that cell adhesion to FN was 
also transiently increased. The increase in adhesion was apparent as a 
significant increase (129%) in the numbers of ruptures per curve (Fig. 2-7A and 
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D, green triangle) and increase in total adhesion force (177%) (Fig. 2-7A and 
E, purple cross). 
 
Figure 2-7. KCl transiently enhanced cell stiffness and cell adhesion to FN as 
well as intracellular calcium level ([Ca2+]i). (A) Group average real-time 
recordings of [Ca2+]i (red), cell stiffness (blue), rupture events (green), and 
rupture force (purple) before and after addition of KCl (n=10). (B) Group 
recordings of [Ca2+]i (red), cell stiffness (blue), rupture events (green), and 
rupture force (purple) normalized to average summed all time points of before-
treatment (n=10). (C) Average elastic modulus summed across all of time 
points and peak response for the group of VSMCs before and after addition of 
KCl (60 mM) (n=10, **P < 0.01). (D) Average rupture numbers per curve 
summed across all of time points and peak response for the group of VSMCs 
before and after addition of KCl (n=10, **P < 0.01). (E) Average rupture force 
summed across all of time points and peak response for the group of VSMCs 
before and after addition of KCl (n=10, **P < 0.01). Data were collected at 0.1 
Hz of indentation frequency and are presented as mean  SEM. 
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Involvement of [Ca2+]i as a mediator of changes in cell stiffness and 
adhesion 
To confirm Ca2+ was changing following KCl treatment, VSMCs were 
loaded with the fluorescent calcium indicator fluo-4. [Ca2+]i measurements were 
obtained while simultaneously performing AFM to measure cell stiffness and 
adhesion to FN. KCl induced a transient increase in levels of [Ca2+]i that 
correlated with the increased cell stiffness, as well as the increases in adhesion 
ruptures and total adhesion force (Fig.2-7A and B, red square). It was noted 
that [Ca2+]i levels reached maximum levels immediately preceding the changes 
in cell stiffness and cell adhesion. These data suggest that calcium-related 
signaling is linked to the observed changes of cell stiffness and adhesion. As a 
further test of the involvement of [Ca2+]i as a mediator of the observed changes 
in stiffness and adhesion, VSMCs were treated with the calcium chelator, 
BAPTA. As shown in Fig. 2-8A, BAPTA-treated groups of cells showed slightly 
decreased stiffness, however this reduction was not statistically significant 
compared to cells of PBS-treated groups. However, average adhesion ruptures 
significantly declined 24% (p<0.01) in BAPTA-loaded cells (Fig. 2-8B) 
compared to the control group. BAPTA treated cells also showed significant 
reduction in total adhesion force, which decreased 25% (Fig. 2-8C). To confirm 
an effect of BAPTA on [Ca2+]i, experiments were performed on fluo-4 loaded 
VSMCs. BAPTA-loaded cells showed significantly decreasing [Ca2+]i compared 
to the PBS-treated control group at p level of 0.01 (Fig. 2-8D). Thus, these data 
further suggest [Ca2+]i plays a role in altering integrin adhesion.  
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Figure 2-8. BAPTA treatment decreased cell adhesion to FN but has no effect 
on cell stiffness. (A) Average elastic modulus for the group of VSMCs with and 
without BAPTA-treatment (10-6 M). (B) Average rupture events per curve for the 
group of VSMCs with and without BAPTA treatment (n=10, **P < 0.01). (C) 
Average rupture for the group of VSMCs with and without addition of BAPTA 
(n=10, **P < 0.01). (D) Level of [Ca2+]I for the group of VSMCs with and without 
addition of BAPTA (n=10, **P < 0.01). Data were collected on randomly 
selected 5 cells, each cell was recorded 2 minutes at 0.1 Hz of indentation 
frequency. Data are presented as mean  SEM. 
 
Effects of inhibition of myosin light chain kinase  
[Ca2+]i elevation leads to VSMC contraction through activation of myosin 
light chain kinase (MLCK) via calcium-calmodulin complex [108]. To further 
investigate the role of [Ca2+]i in cell stiffness and adhesion to FN, VSMCs were 
treated with ML7, a myosin light chain kinase inhibitor prior to treatment with 
KCl. [Ca2+]i was also measured using fluo-4. After ML-7 treatment, VSMCs E-
modulus was decreased to 35% when it was normalized to pre-drug period (Fig. 
2-9B, blue circle) measured during the last 10 minutes of ML-7 treatment period 
compared to pre-drug period in cell stiffness (Fig. 2-9C) but there was no effect 
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on adhesion ruptures (Fig. 2-9D) or adhesion force (Fig. 2-9E). [Ca2+]i was not 
significantly increased by ML-7 and then back to base. Compared to pre-drug 
condition (Fig. 2-10A), ML-7 treated VSMC exhibited a loss of stress fibers or 
the large bands of actin cytoskeletal filaments underlying the cell membrane 
(Fig. 2-10B). Topographic images of the VSMCs also revealed cell height 
decreased following ML-7 (FIG. 2-10C and D). Following application of KCl to 
the ML7-treated cells (Fig. 2-9A, blue circle) there were no observable changes 
on the effect of KCl on stiffness or adhesion as either rupture numbers or 
adhesion force. Therefore, these results further support the involvement of 
[Ca2+]i in cortical cell stiffness and adhesion to FN and further suggest that 
increased cell stiffness and adhesion was not dependent on actin-myosin 
interaction.  
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Figure 2-9. With pre-treatment of ML-7, KCl elevated cell stiffness, cell 
adhesion to FN as well as level of [Ca2+]i. (A) Group average real-time 
recordings of [Ca2+]i (red), cell stiffness (blue), rupture events (green), and 
rupture force (purple) before and after addition of ML-7 and KCl (n=10). (B) 
Group recordings of [Ca2+]i (red), cell stiffness (blue), rupture events (green), 
and rupture force (purple) normalized to average summed all time points 
without treatment (n=10). (C) Average elastic modulus summed across all time 
points for the group of VSMCs before treatment, time points of 15 minutes of 
ML-7 (15 m) and first 3 time points after addition of KCl (60 mM) (n=10, *P < 
0.05 compared to no-treatment, #P < 0.05 compared to ML-7). (D) Average 
rupture numbers per curve summed across all time points for the group of 
VSMCs before treatment, time points of 15 minutes of ML-7 (15 m) and first 3 
time points of after addition of KCl (60 mM) (n=10, *P < 0.05 compared to no-
treatment, #P < 0.05 compared to ML-7). (E) Average rupture force summed 
across all of time points for the group of VSMCs before treatment, time points 
of 15 minutes of ML-7 (15 mm) and first 3 time points of after addition of KCl 
(60 mM) (n=10, *P < 0.05 compared to no-treatment, #P < 0.05 compared to 
ML-7). Data were collected at 0.1 Hz of indentation frequency and are 
presented as mean  SEM. 
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Figure 2-10. Contact-mode images of VSMCs with ML7. (A-B) Images of 
deflection error of single cultured VSMC of before treatment (A) and after ML7 
treatment (B). (C-D) Height images of single cultured VSMC of before 
treatment (C) and after addition of ML7 (D).   
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DISCUSSION 
Previously, Hong et al. [66] have shown in VSMCs that vasoactive 
agonists induced coordinated changes in cell elasticity and integrin-mediated 
cell adhesion. That specifically, vasoconstrictors increase VSMC elastic 
modulus and simultaneously enhance cell adhesion whereas vasodilators have 
the opposite effect [66]. In this study, our results confirm that the regulation of 
ECM adhesion and the contractile activation state of vascular smooth muscle 
are dynamically linked. The results also demonstrate this coordinated link is 
synchronized with [Ca2+]i. We tested the hypothesis that the contractile 
activation of VSMCs with elevated [Ca2+]i would enhance adhesion to the ECM 
protein FN and that the change in adhesive behavior would be coordinated with 
increases in VSMC cortical stiffness. The increase in cortical stiffness was 
assumed to act as an indication of changes in the state of VSMC contractile 
activation. As a corollary to this, we postulated that lower [Ca2+]i would produce 
opposite results characterized by decreased adhesion to FN and a parallel 
reduction in VSMC cortical stiffness.  
Real-time fluo-4 confocal image combined with AFM was used to record 
cell stiffness and adhesion to FN along with [Ca2+]i. We confirmed that 
increases in cell stiffness and adhesion to FN occurred in the presence of a 
rapid but transiently increase [Ca2+]i that  was induced by KCl. The results 
indicated a high degree of correlation between the increase in [Ca2+]i and cell 
stiffness and adhesion. As contraction of VSMC follows from increased [Ca2+]i, 
we inhibited the contractile interaction of actin and myosin with ML7. By 
preventing contractile filament interaction, we sought to determine whether the 
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changes in cortical stiffness and cell adhesion were linked as a downstream 
event of the contractile process or occurred as a set parallel events coordinated 
with contraction through changes in [Ca2+]i.  The results of these experiments 
indicated that the changes in cell stiffness and adhesion persisted in the 
presence of the inhibition of MLCK supporting the interpretation that that 
coordination with contraction is likely regulated by a pathway parallel to but not 
downstream of contraction. We then sought to lower [Ca2+]i by Incubation with 
the calcium chelator BAPTA. We reasoned that lowering [Ca2+]i would not only 
inhibit contractile filament interaction but would also inhibit any parallel pathway 
dependent on [Ca2+]i. The results confirmed that lowering [Ca2+]i reduced cell 
stiffness  and cellular adhesion to FN providing additional support for the 
conclusion that there is a parallel pathway activated upstream of the contractile 
pathway. 
The cytoskeleton of VSMC provides a structural framework that 
determines cell shape/morphology and mechanical properties. These 
characteristics are determined by both dynamic actomyosin interactions as well 
as by the capacity of the actin cytoskeleton to rapidly depolymerize and 
repolymerize [109]. In this study, the protocol used to measure VSMC stiffness 
resulted in cell surface indentation by the AFM probe of ~100-300 nm. Thus, 
the changes in measured cell elasticity should be viewed as largely 
representing the cortical stiffness of the cell’s stress fibers underlying the cell 
membrane. It is well established that the cortical cytoskeleton network 
physically connects to deeper cytoskeletal elements within the cytosol as well 
as to adhesion zones that regulate adhesion to the ECM [110-112].  Cortical 
stiffness is mechanically determined by cellular cortex elasticity and cortex 
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tension, which is believed to be mostly governed by myosin-generated 
contractility [113, 114]. The changes in VSMC stiffness we observed in the 
presence of inhibition of MLCK are consistent with interpreting the alterations 
in stiffness as changes in the polymerization state of the cortical cytoskeleton. 
Phenylephrine (PE) is another vasoconstrictor that has also been 
reported to induce cortical stiffening in VSMC without affecting focal adhesion 
size via FAK-ERK signaling. These data support a correlation between cellular 
cortical stiffness and cellular contractile state [115]. Together with the present 
result that pretreatment of ML-7 did not blunt KCl effects on cell stiffness and 
adhesion (Fig. 2-9), these data further indicate calcium exerts its effect via 
calcium-related signaling pathway other than downstream of actin myosin 
interactions. Given previous findings from Hong et al. that cytoskeletal 
remodeling occurs in VMSCs following AII treatment [62], calcium appears to 
exert its effect on cell stiffness through changes in actin polymerization. 
Calcium-calmodulin-dependent protein kinase II (CaMKII) has been reported to 
regulate actin cytoskeletal assembly [116], which might suggest a possible 
mechanism of calcium effect. However, more experiments will be needed to 
demonstrate underlying mechanisms of involving cytoskeletal remodeling and 
calcium.  
The responsiveness of VSMCs used in this study to AII confirmed the 
retention of characteristics expected of a contractile phenotype. This is 
important because cultured VSMCs carried in culture over many passages 
exhibit a transition from a contractile phenotype to a synthetic phenotype [117, 
118]. In our studies, only primary cell cultures were used without passage to 
minimize these phenotypic changes. Despite these precautions, it is not 
  46 
possible to completely prevent phenotypic shifting and this may account for why 
only 80% of the cells we studied were AII responsive (data not shown). 
VSMCs cellular adhesion to FN was assessed by measuring the force 
required to produce rupture events between the FN coated AFM probe 
adhering to the VSMC. This was quantified as number of rupture events per 
force curve and the force that break adhesion bonds formed between VSMCs 
and FN on the AFM probe. An increase in detectable rupture events and/or 
force was interpreted as a change in integrin-mediated cell adhesion. Another 
possibility is that an increase in the number of rupture events induced by an 
agonist might be related to mechanical wrinkling or ruffling of the cell membrane 
that decreases the cell surface area such that integrin density per unit 
membrane area would be augmented and impact the number of detected 
adhesions. However, pretreatment of VSMC with ML-7 to prevent any cell 
contraction, did not change KCl-induced adhesion to FN (Fig. 2-9). This 
evidence argues against a membrane contraction-induced change in integrin 
density.  Also, in previous studies by Hong et al. [66] increases in adhesion 
force were detected following AII suggested that the increase in adhesion was 
accompanied by changes in the molecular connections of the integrin to 
cytoskeletal components. This also argues against argument of the change in 
membrane area. 
Previous studies have shown that adhesion events and corresponding 
rupture forces measured by FN-decorated AFM probes are specific interactions 
between FN and 51 integrins [88, 96]. Thus, in this study, changes in 
adhesion is also likely 51 integrin-dependent. It has been demonstrated in 
migratory cells that integrin trafficking to and from the membrane can regulate 
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focal adhesion size through assembly and/or disassembly resulting in spatial 
integrin redistribution of membrane integrins [119]. In our study, to assess 
whether there was a possible change of integrin expression on membrane that 
could contribute to an increase in adhesion via the number of detectable rupture 
events, we coated spherical AFM probe with anti-5 antibody. The anti-5 
antibody that was selected shows affinity for both active and inactive forms of 
the 5 integrin. We reasoned that if the AII was increasing the amount of integrin 
on the membrane then the anti-5 antibody would show an increase in adhesion 
events following AII.  Our results demonstrated that there was no change in 
adhesion to the anti-5 antibody coated AFM probe following AII treatment (Fig. 
2-5). These data support the interpretation that AII-induced changed in 
adhesion to FN was occurring through a process of integrin activation rather 
than integrin turnover.  
In summary, our studies show coordination of VSMC cortical stiffness 
and cell adhesion following contractile activation that is synchronized with 
changes in [Ca2+]i. ML-7 results further confirmed cell stiffness was related to 
contractile state since inhibition of MLCK reduced resting cell stiffness, but ML-
7 did not inhibit KCl induced coordination of enhanced cortical stiffness and 
adhesion to FN. These observations suggest that calcium-induced cell stiffness 
and adhesion is parallel to the contractile activation pathway and not 
downstream of actin and myosin interaction. This information is an important 
advance in our understanding of the mechanisms underlying coordination of 
cell stiffness and adhesion to ECM. We propose this coordination is essential 
to provide the mechanical efficiency and ability of the VSMCs to appropriately 
adapt itself to mechanical changes brought about through intracellular 
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contractile activation and likely extracellular changes in applied force. 
Increased vascular stiffness is a significant feature of aging and occurs in 
cardiovascular disease, such as hypertension and atherosclerosis [30, 31]. 
Further investigations into the underlying mechanisms governing both the 
cellular mechanics and adhesion of VSMC may lead to possible therapeutic 
targets that through the link between these pathways and vascular disease.  
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CHAPTER III 
INTEGRIN ADHESION RESPONSE TO VERTCIAL 
OSCILLATIONS 
ABSTRACT 
Physical coupling of vascular smooth muscle cells (VSMCs) to 
extracellular matrix proteins (ECM) by integrins is required for efficient 
mechanotransduction. Integrin adhesion receptors are essential for normal 
vascular function and defective integrin signaling at focal adhesions is 
associated with cardiovascular disease. Vascular smooth muscle cells 
(VSMCs) are continuously exposed to dynamically changing mechanical forces 
related to changes in arterial pressure, pulse pressure and shear forces. 
However, little is known about focal adhesion and integrin behavior in the 
presence of dynamic changes in the forces acting at the focal adhesion. The 
overall purpose of the study was to gain insight into focal adhesion and integrin 
behavior by using a combination of mathematical modelling supported and 
informed by biological experiments. Mathematical models are a useful tool for 
gaining quantitative insights into the behavior of complex dynamic systems 
through their ability to predict biological behavior in response to change. In this 
study, we collaborated with applied mathematicians to test a model simulation 
of how integrin adhesions respond to changes in mechanical force applied as 
a vertical oscillatory force. Model simulations predicted that integrin adhesions 
would exhibit ‘bistability’ depending on the level of the applied mechanical load. 
The bistability would present as a change in the point at which all integrin bonds 
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rupture depending upon whether load is increasing from a completely bound 
state or decreasing beginning with an unbound state. We used atomic force 
microcopy (AFM) to experimentally mimic the applied vertical oscillation in force 
that were simulated in the model to attempt to verify this model prediction. The 
AFM probe was operated to cyclically approach and retract a fibronectin (FN)-
coated spherical AFM probe from the cell surface. Two conditions were 
compared, one in which the probe was pre-bound to the cell to form an 
established focal adhesion and the second in which there was no prebinding of 
the probe to the cell. Retraction amplitudes were varied by setting different 
retraction ramp sizes. The results indicated that at retractions from the cell 
surface of 1000 nm and shorter integrin adhesion to FN dominated over integrin 
adhesion ruptures as the small retraction amplitudes were not sufficient to 
detach the integrins from the FN on the AFM probe. At larger amplitude 
displacements, for example 2000 nm retraction ramp size, there was sufficient 
probe separation from the cell surface to cause complete rupture of all integrin 
bonds with each cycle regardless of initial integrin bonds formed on contact. 
This was true for both the pre-bound and non-prebound conditions. However, 
for intermediate amplitude retraction distances, for example, 1200 nm ramp 
size, pre-bound and non-pre-bound results differed. In the prebound condition 
the integrin adhesions were more resistant to disruption and adhesion prevailed 
whereas in the non-pre-bound condition integrin adhesion ruptures showed 
dominance. In conclusion, our experimental data support the existence of 
“bistability’ for integrin adhesions that is dependent on initial conditions of 
adhesion and thus support the model predictions. The bistable nature of 
adhesion behavior in the presence of dynamic oscillations suggest that integrin 
  51 
signaling could be quite different depending on the balance between integrin 
adhesion vs. adhesion rupture. 
INTRODUCTION 
Many vascular functions are associated with mechanical forces including 
regulation of blood pressure, tissue blood flow, capillary pressure, peripheral 
resistance, permeability, leukocyte adherence, and vascular remodeling [120-
122]. As the major cellular component of arterial vessels, vascular smooth 
muscle cells (VSMCs) are constantly exposed to mechanical stimuli in their 
environment and have evolved several mechanisms to sense and respond to 
these cues. The process that vascular cells are to sense mechanical forces and 
change them into intracellular signals to elicit specific cellular response is 
known as mechanotransduction, and is linked to changes in the cell contractile 
state as well as gene expression, growth and cell phenotype [123-125]. Existing 
data supports the idea that mechanotransduction is linked to a variety of cell 
surface proteins of which, integrins appear to play a central role [125, 126]. 
Integrins provide a direct link from the extracellular matrix (ECM) environment 
to the cytoskeleton and can bi-directionally transmit physical forces and play a 
role in outside-in and inside-out signaling. Upon binding with ECM proteins, 
integrins cluster together and recruit through their intracellular domains 
numerous scaffolding and signaling proteins to form the focal adhesion 
complex [17, 127]. 
The involvement of integrins in mechanotransuction has been 
extensively studied for both ‘outside-in’ pathways and ‘inside-out’ pathways. 
From ECM to the cell, it has been shown that integrins act as sensors of 
mechanical properties generated within the local microenvironment and convey 
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this information to the cell. It is well accepted that ECM-cell interactions are 
dynamic processes. In this regard, vascular smooth muscle cells (VSMCs) are 
exposed to continuously changing mechanical forces related to changes in 
arterial pressure, pulse pressure and shear forces. However, little is known 
about focal adhesion and integrin behavior in the presence of dynamic changes 
in the forces acting at the focal adhesion. This information is important to 
understand how cell signaling and ultimately cell and vascular behavior will be 
influenced. The overall purpose of the study was to gain insight into focal 
adhesion and integrin behavior by using a combination of mathematical 
modelling supported and informed by biological experiments. Mathematical 
models provide a useful approach for gaining quantitative insights into the 
behavior of complex dynamic systems through their ability to predict biological 
behavior in response to change. To date there very few published mathematical 
models of integrin-related cellular process [128, 129], and there are no studies 
using mathematical models to try to understand integrin behavior to 
dynamically changing forces. 
In this study, we combined our biological expertise for study of integrin 
behavior in VSMCs with the mathematical modeling expertise of colleagues. A 
mathematical model of integrin adhesion behavior was developed that 
simulated the behavior of integrin adhesions in response to oscillating 
mechanical stretching of different magnitudes. In this study, we used atomic 
force microcopy (AFM) to experimentally mimic the applied vertical oscillation 
in force that were simulated in the model to attempt to test model predictions. 
The model simulations predicted that integrin adhesion would vary dependent 
on applied force amplitude and initial conditions of integrin adhesion to the 
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ECM. We directly tested these predictions by using a fibronectin (FN)-coated 
AFM probe that could be controlled to interact with the cell to mimic the model 
simulations.  
METHODS 
Mathematical simulation model 
 
Figure 3-1. Illustration of 3-spring model for vertical oscillation. The 3-spring 
model for vertical deformation of linear elastic materials representing the cell, 
bound integrins, and the ECM. The cell, integrins, and ECM springs have rest 
length LA, LR, and LE and deformed length L’A, L’R, and L’E respectively. The 
total fraction of bound integrins is given by 𝐵(𝑡) = ∫ ?̂?
∞
−∞
(?̂?, ?̂?) 𝑑𝑥 , and the 
integrin spring strength is proportional to this quality. For predictions of integrin 
adhesion behavior, the vertical amplitude was cyclically varied through a series 
of different amplitudes representing low, intermediate and high stretches. 
 
Figure 3-1 illustrates a schematic model of an integrin focal adhesion 
interacting with the extracellular matrix (ECM). In this 3-spring model, the 
vascular smooth muscle cell (VSMC), integrins and ECM are each represented 
as linear springs with the spring constants A, I, E, respectively. The spring 
constants A, I, E represent the cell stiffness, collective stiffness of bound 
integrins (acting in parallel) and ECM stiffness, respectively. The resting lengths 
of the springs are represented by LA, LR, and LE and force induced deformed 
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lengths are represented as L’A, L’R, and L’E, respectively. The total fraction of 
bound integrins is given by the integral:  𝐵(𝑡) = ∫ ?̂?
∞
−∞
(𝑥, ?̂?) 𝑑?̂? , and it is 
determined by integrins () distribution ?̂?(?̂?, ?̂?), and distance 𝑑𝑥 between the 
integrin and the ECM. The integrin-bound fraction takes on a value between 0 
and 1 with 0 representing no bound integrins and 1 representing all integrins 
fully bound. The total number of bound integrins at any point in time is given as 
B. According to Hooke’s law, the vertical adhesive force is given by ?̂?𝑦(?̂?) =
𝜌?̂?𝑏𝐵?̂? , in which ?̂?𝑏 is integrin spring constant, and ?̂?  is integrin extended 
distance. 
Using this model, a vertical oscillatory displacement was applied by 
varying the y-coordinate, L’T, to the location of the ECM. This is represented by 
the following equation: 
𝐿′𝑇 =
𝐿𝑇 + 𝐴
2
+ 𝐴(−1)[2𝜔𝑡+1] (
1
2
+ 2𝜔𝑡 − [2𝜔𝑡 + 1]) 
where LT/2 is minimum height of the oscillating layer (i.e. when the approach of 
the ECM to the cell is complete), A is the magnitude of the oscillation, and  is 
the frequency of oscillation. This model generates a trace of the time courses 
of the fraction of bound integrins, B, and vertical adhesion forces as we vary 
the amplitude A in the wave equation. This model was developed in 
collaboration with Dr. Bindi Brook, Dr. Reubin O’Dea and Linda Irons at the 
University of Nottingham. These model predictions were then experimentally 
tested on isolated aortic VSMCs using an atomic force microscope (AFM). The 
AFM probe was labelled with ECM and the AFM used to control and mimic the 
oscillation pattern used in the model. The methods for the biological 
experiments follow. 
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Materials and reagents used 
For all cell isolations, dithioerythriotol, papain, collagenase, soybean 
trypsin inhibitor, and elastase were purchased from Sigma (St. Louis, MO, 
USA).  For studies described human plasma fibronectin (FN), Bovine Serum 
Albumin (BSA), and PEG were purchased from Sigma (St. Louis, MO, USA). 
For studies using atomic force microscopy (AFM) a bioscope II AFM system 
(Bruker, Santa Barabara, CA, USA) was mounted on an IX81 OLYMPUS 
inverted microscope (Olympus Inc., Thorwood, NY). AFM data were collected 
and analyzed using Nanoscope (Bruker, Santa Barbara, CA, USA) and Matlab 
(MathWorks, Natick, MA, USA) software. 
Cell preparation 
Animal and Tissue preparation 
Male Sprague-Dawley rats (200 g-300 g) were used in this study and 
were maintained in accordance with the protocol of the Guide for the Care and 
Use of Laboratory Animals (NIH 83-23, revised 1996). The animal protocol was 
reviewed and approved by the Laboratory Animal Use Committee (ACUC) of 
the University of Missouri. Animals were housed individually in a 12:12 light- 
dark cycle and had free access to food and water. Tissue samples of the 
thoracic aorta were isolated as described in previous work [130]. Briefly, rats 
were anesthetized by intraperitoneal injection of pentobarbital sodium 
(Lundbeck, Inc., Deerfield, IL, USA) at 0.1 g/kg. A surgical plane of anesthesia 
was confirmed by observing no spinal reflex to a toe pinch. The rat chest was 
opened and the thoracic aorta from the descending thoracic aorta to the 
diaphragm excised (~ 1-2 cm) placed quickly to in cold (4oC) Ringer’s buffer 
(composed of 145 mM NaCl, 4.7 mM KCl, 2.0 mM CaCl2(2H20), 1.0 mM 
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MgSO4(7H20), 1.2 mM NaH2PO4(H2O), 0.02 mM EDTA, 3.0 mM MOPS, 5 mM 
Glucose, 2.0 mM Pyruvic Acid). Vessel and cell isolation were performed in 
solution based on Ringer’s buffer. Anesthetized rats were euthanized by 
intracardial injection of saturated KCl solution (3 ml).  The aorta tissue was 
moved on a silicone rubber pad in a bath of cold Ringer’s buffer and cleaned of 
fatty tissue. After draining of blood by changing buffer solution, the adventitial 
layer was carefully isolated and removed with help of a stereomicroscope. The 
aorta was then cut open longitudinally, and then endothelium was gently 
scrapped off with finely-toothed forceps and aortic tissue minced into 
approximately 1 mm2 squares. The tissue pieces were then placed into culture 
dish (35 cm2) with Ringer’s buffer in room temperature and subsequently 
processed to isolate vascular smooth muscle cells (VSMCs).  
VSMCs isolation and culture 
VSMCs were enzymatically isolated using previously described methods 
with minor modification [104].  Briefly, thoracic aortic pieces were transferred to 
a glass culture tube (10 ml) that contained 1 ml of the first cell dissociation 
solution consisting of Ringer’s solution, 27 U/ml of papain and 1mg/ml 
dithioerythriotol. The segments were incubated at 37 oC for 45 minutes without 
agitation. At the end of this interval, the first cell dissociation solution was 
carefully decanted and replaced with 1 ml of second cell dissociation solution 
consisting of Ringer’s solution with 0.5 U/ml collagenase, 75 U/ml elastase, and 
1 mg/ml soybean trypsin inhibitor. The segments were further incubated for 30 
minutes at 37 oC. At the end of the incubation period, the dissociation solution 
was carefully decanted and washed twice by adding 1 ml Hank’s solution, 
followed by 1 ml serum free DMEM/F12 (Invitrogen, Carlsbad, CA, USA) The 
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vessels segments were triturated by pipetting 2 ml DMEM for approximately 20-
30 times to disperse individual cells from the tissue. The solution containing the 
dispersed VSMCs was then transferred into 60 mm tissue culture dishes 
(Corning incorporated, Corning, NY, USA), and maintained under culture 
conditions in a humidified incubator with 5% CO2, at 37oC in DMEM 
supplemented with 20% fetal bovine serum (FBS, ATLANTA Biologicals, 
Laurenceville, GA, USA), 10 mM HEPES (Sigma, St. Louis, MO, USA), 1 mM 
sodium pyruvate, 2 mM L-glutamine, 100 U/ml penicillin, and 100 g/ml 
streptomycin. After 48 hours’ incubation, the culture medium was changed to 
DMEM/F12 supplemented with 10% FBS.  The cells used in all experiments 
were maintained under these conditions for 5-10 days without passage. Prior 
to an experiment the VSMCs were serum-starved overnight.  
Force spectroscopy measurement 
Bio-functionalized AFM probes  
A 5 m diameter glass bead (Structure Probe Inc., West Ghester, PA, 
USA) was glued on the tip of an AFM probe (MLCT-O10, Bruker Corp., Santa 
Barbara, CA, USA) and then coated with FN using the protocol previously used 
in our Laboratory [88]. Briefly, before gluing the glass bead to the cantilever tip, 
each cantilever was calibrated before a given experiment using thermal noise 
amplitude analysis. Cantilevers were then cleaned first by rinsing in 100% 
ethanol twice followed by rinsing in acetone for 3 times. The cantilever was 
dipped in glue (Progressive Epoxy Polymers Inc., USA) and then brought into 
contact with a glass bead mixture in solution that had been smeared on a glass 
slide. After bead attachment AFM probes were stored for 48 hours to allow 
bead glue to cure. The AFM probe with attached bead was then processed to 
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bio-coat the bead tip. Polyethylene glycol (PEG, Sigma, St. Louis, MO) was 
used as cross-linker for attachment of proteins of interest to the bead.  The tip 
was first incubated with 10 mM PEG for 5 minutes, followed by washing four 
times with distilled water, and then incubated with FN (1 mg/ml) for 5 minutes, 
followed by rinsing four times with phosphate-buffered saline (PBS) (1.05 mM 
KH2P04, 155.17 mM NaCl, 2.96 mM Na2HP04-7H20).  For all experiments, the 
AFM spring constants were assumed to be unchanged after protein labeling.  
Vertical oscillation protocol of AFM 
Monitoring of biomechanical properties of single live VSMCs in real time 
was performed using a Bioscope II AFM system that was mounted on an IX81 
OLYMPUS inverted microscope. All AFM measurements were conducted at 
room temperature in a 1% HEPES supplemented DMEM without antibiotics. To 
minimize drift, after the probe was initially submerged in the cell bath and the 
whole system was thermo-equilibrated for 1 hour. After thermal equilibration, 
the FN-coated spherical probe (Fig. 2-1D) was used to repeatedly indent and 
retract from the cell surface at 0.1Hz sampling frequency. To determine the 
effect of withdrawal ramp size on the adhesion characteristics between FN and 
the VSMC, ramp sizes were varied throughout a range from 200 nm to 2000 
nm. Force curves were obtained for ramp increases at steps of 200 nm over 
the entire range. Two types of protocols were followed for each ramp size. The 
first is a Prebind protocol in which the AFM probe was allowed to attach onto 
the VSMC and the second a Non-prebind protocol in which the probe was not 
pre-attached to the VSMC.  
(1) Pre-Bind Protocol: An AFM probe with a FN-coated bead attached was brought 
into contact with the VSMC surface. The probe with bead was maintained in 
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contact with the cell membrane for 20 minutes to allow formation of a stable 
focal adhesions. After 20 minutes, the oscillation experiments were performed.  
(2) Non-Prebind Protocol: An AFM probe with a FN-coated bead attached was 
brought into contact with the VSMC surface. The AFM was set to immediately 
begin oscillating by performing approach and retraction cycles after it engaged 
the cell membrane. In this protocol, there was no delay period of contact with 
the cell to allow formation of a focal adhesion. 
For each experiment, cells were randomly selected and indented on the 
nucleus site, and 60 force curves were collected over 10 minutes. All of AFM 
measurements were conducted at room temperature in serum-free medium. 
The analysis of force curves was processed by a custom analysis program 
written in MATLAB. 
AFM measurements 
Measurements of pulling force, bead displacement, and distance 
between ECM and the cell were collected and calculated from continuous force 
curves. The pulling force was generated by the bending of the AFM cantilever 
and was calculated according to Hooke’s law as follows:  
𝐹 = 𝑑 ×  𝑘 
where F is force (in pN), d is cantilever deflection (in nm), and k is the cantilever 
spring constant (in pN/nm). Bead displacements were recorded for 10 minutes 
and reconstructed by Matlab. Distance between ECM and the cell was 
calculated by total ramp size minus displacement of initial contact point.  
Statistical analysis 
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Experimental data of non-prebind and prebind condition were compared 
in statistical difference by two-sample Kolmogorv-Simirnov test. Differences 
were considered significant at P  0.05. 
RESULTS 
In the simulation model described in the methods, the cell, integrins, and 
ECM were represented by linear springs and a vertical oscillatory displacement 
was imposed with amplitude A. In experiments, amplitude was applied through 
ramp size of AFM from 200 nm to 2000 nm.  
Model predictions versus experimental results 
1. Low amplitude displacement simulation and experimental results 
1.1 Simulation model 
Low amplitude oscillations were simulated as = 2, that the bound 
fraction stays high as there is insufficient separation distance between the ECM 
and the cell to create full rupture of bound integrins. For the non-pre-bind 
condition (Fig. 3-2A red line), when the ECM layer approached the cell 
membrane, integrin bonds were formed over time and reached an equilibrium 
or bound saturation point relative to the duration of contact. Given the low 
amplitude oscillations of displacement there are only small amounts of integrin 
ruptures for each cycle. In the pre-bind condition (Fig. 3-2A blue line), a 
maximum number of integrin bonds form in advance of imposing the oscillatory 
displacements. Similar to the non-pre-bind condition, the majority of integrins 
remain attached and a small amount of oscillatory rupture fraction was 
observed. Thus, the adhesion behavior to applied oscillatory force under pre-
bind condition and non-pre-bind condition were equivalent and adhesion 
dominates over adhesion rupture. 
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Figure 3-2. Low amplitude oscillatory simulation and experimental results. (A) 
Integrin bound fraction in simulation at low amplitude (A = 2) stretching. (B) For 
low amplitude (A = 2) in the simulation model, result of force, ECM 
displacement, and distance between ECM and cell are displayed. (C) At 
experimental amplitude 1000 nm, result of force, bead movement, and distance 
between bead and cell. Most of integrins maintain adhesion and the low 
amplitude oscillations cause only a small fraction of integrin ruptures in both 
simulation model and experimental results. In other words, integrin adhesion 
dominates over integrin rupture in the presence of low amplitude stretching 
because imposed stretch is insufficient to induce rupture. 
 
1.2 Comparison of experimental data to model predictions 
AFM experiments on VSMCs were performed at displacement ramp 
sizes of 200 nm – 1000 nm to test the mathematical model predictions for low 
amplitude oscillations. Figure 3-2C presents a representative data set collected 
at ramp size of 1000 nm and an oscillation frequency of 0.1 Hz on a thoracic 
VSMC. These experiments were performed without an AFM pre-attachment of 
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the FN coated AFM probe to the VSMC (non-prebind condition). The distance 
between FN-coated bead and the cell slightly increased with applied oscillatory 
displacement and applied force, which is consistent with the mathematical 
simulation (Fig. 3-2B). Upon contacting the VSMC with FN, integrin adhesions 
formed and saturated over the duration of the oscillating contact period. As the 
distance between bead and cell was only slightly increased, most of the integrin 
bonds survived and did not rupture. Thus, the experimental data at 1000 nm 
supported this mathematical model in low amplitude oscillatory force ( = 2). 
2. High amplitude displacement simulation and experimental results 
2.1 Simulation model 
High amplitude oscillations were simulated as = 4, and in this 
condition, applied oscillational displacement and forces are sufficiently large 
that there is full adhesion detachment at each cycle of the oscillation. In other 
words, all integrin adhesions with the ECM rupture. As illustrated in Figure 3-
3A, in both zero (red line) and saturated (blue line) initial condition, applied 
oscillatory force was large enough to completely break the ECM and the rupture 
fraction dominated for the cell and integrin bonds. Due to the large 
displacement amplitude, the adhesion predicted behavior was the same for the 
pre-bind condition and non-pre-bind conditions.  
2.2 Comparison of experimental results to model predictions 
To mimic the high amplitude displacement simulation, AFM experiments 
on VSMCs were performed at ramp size of 2000 nm to test the mathematical 
model predictions. Figure 3-3C showed a representative data set that was 
collected at ramp frequency of 0.1 Hz on a VSMC without forming saturated 
integrin bonds (non-prebind). As depicted in Figure 3-3C, distance between FN-
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coated bead and the cell was augmented by increased displacement and 
applied force. We found that a 2000 nm ramp sized was large enough to 
completely break all bonds formed between the FN-coated AFM probe and the 
VSMC. These data are entirely consistent with and supportive of the predictions 
of the mathematical model (Fig. 3-3B).  
 
Figure 3-3. High amplitude oscillatory simulation and experimental results. (A) 
Integrin-bound fraction in simulation model for high amplitude (A = 4) stretches. 
(B) For high amplitude (A = 4) in the simulation model, result of force, ECM 
moved distance, and distance between ECM and the cell are displayed. (C) At 
experimental amplitude 2000 nm, result of force, bead movement, and distance 
between bead and cell were determined. High amplitude stretches cause all 
integrin adhesions to rupture for each cycle of stretch in both simulation model 
and experimental results. Stretch exceeds adhesive potential of the bound 
integrin fraction and adhesion rupture dominates over adhesion. 
 
3. Intermediate amplitude displacement simulation and experimental results  
3.1 Simulation model 
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For intermediate displacement, a value of  = 2.475 was selected. Under 
intermediate displacement the model predicted two possible outcomes that 
were dependent on the initial binding conditions (Fig. 3-4A). For the non-
prebind condition where there are zero-initial existing adhesions (Fig. 3-4A, 
red), there is full rupture of all adhesions because the separation distance 
between the cell and ECM was sufficiently large to rupture the individual 
adhesions. However, under the pre-bound condition (Fig. 3-4A, blue), the 
integrin adhesions showed resilience in the presence of the displacement and 
there was adhesion survival. Thus, integrin adhesions exhibited two types of 
behavior in response to intermediate level displacement, which we defined as 
‘bistability’.  As shown in Figure 3-4B, at the same applied oscillatory force, 
ECM-cell separation distance was larger in non-pre-bound (blue) condition than 
in the pre-bound condition.  
3.2 Comparison of experimental results to model predictions 
To replicate the intermediate amplitude displacement simulation, AFM 
experiments on VSMCs were performed at ramp size of 1200 nm to test the 
mathematical model predictions. Representative results of an experiment 
representing the non-prebind initial condition (Fig. 3-4C) and pre-bind initial 
condition (Fig. 3-4D) display force and bead-cell separation, respectively.  For 
the non-prebind condition (Fig. 3-4C), adhesion ruptures were observed 
indicating that the displacement was sufficient to disrupt the integrin adhesions. 
However, adhesion ruptures were not observed in the pre-bind condition (Fig. 
3-4D). Furthermore, cells in pre-bind condition showed shorter separation 
distance of bead-cells than those in non-prebind condition. These experimental 
results closely match the predictions resulting from the mathematical model 
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(Fig. 3-4B). Thus, experimental results provided evidence supporting 
‘bistability’ behavior of integrin adhesions.   
 
Figure 3-4. Intermediate amplitude oscillatory results for simulation and 
experimental studies demonstrate ‘bistability’. (A) Integrin bound fraction in 
simulation model of intermediate amplitude (A = 2.475). (B) For intermediate 
amplitude (A = 2.475) in simulation model, result of force, ECM moved distance, 
and distance between ECM and cell are displayed. (C) At experimental studies 
an amplitude of 12000 nm represented intermediate stretch, result of force, 
bead movement, and distance between bead and cell are displayed. For 
intermediate amplitude oscillations, the dominance of Integrin adhesion versus 
integrin rupture has different outcomes based on initial conditions of the integrin 
ECM interaction. Cells of non-prebind condition that prevent formation of an 
established focal adhesion showed larger cell-bead separation distance on 
stretching than did cells that were pre-bound to the ECM and had established 
focal adhesions. This revealed a transition state at which rupture would begin 
to dominate over adhesion. 
 
DISCUSSION 
In this study, we provide experimental data to test a mathematical model 
of integrin binding to the ECM in response to vertical oscillations of 
displacement distance between the ECM and the cell. Model simulations were 
designed based on two initial conditions. The first condition was what is referred 
to as non-prebind in which there exist zero-integrin ECM bonds under the initial 
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condition. This was achieved by starting oscillations immediately after the AFM 
probe was engaged to cell surface. The second condition is referred to as pre-
bound in which the ECM and cell have had sufficient time to interact to allow all 
available integrins to bind to the ECM creating a saturated-integrin bond initial 
condition. To experimentally replicate the non-prebind condition, we used a FN-
coated AFM to approach and retract cyclically from the cell surface. By 
comparison, to mimic the pre-bind condition we engaged the FN coated with 
the VSMC for a 20-minute period to allow adhesion to the FN and formation of 
a focal adhesion before initiating cyclic retraction/approach.  Previous studies 
from our laboratory have shown that 20 minutes of contact with and FN-coated 
AFM probe allows consistent and stable focal adhesion formation between the 
FN-conjugated bead and cell surface integrins which was confirmed by the 
presence of 5-integrins and actin clustered around the circumference of the 
bead [88, 127].  
Based on the predictions of the simulation model, it can be seen that 
integrin adhesion to the ECM is determined by the presence of initial integrin 
bonds and amplitude of applied oscillatory force/displacement. Simulations with 
both low and high amplitude oscillatory force/displacement, cell integrin 
adhesion to ECM predicted similar behavior in both pre-saturated initial 
condition and non-prebind zero-formed integrin bonds condition. Integrin 
adhesion dominated over ruptures in low amplitude simulation while high 
amplitude induced complete break of integrin bonds and rupture dominated 
adhesion. In contrast, for intermediate amplitude simulation, integrin adhesion 
demonstrated ‘bistability’ with adhesion behavior showing two possible 
outcomes that depended on the initial condition. Under pre-bind conditions 
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adhesion dominated over adhesion rupture whereas under non-prebind 
conditions adhesion rupture began to be exhibited. These simulations 
suggested that prebinding placed the integrins in an enhanced state of stability. 
Experimental classification of high/low/intermediate adhesion states 
To experimentally test the proposed mathematical model, we first had to 
determine the range of displacements required to mimic the high, low and 
intermediate adhesion sates. In the simulation model, the classification of the 
adhesion states is determined by the bound fraction of integrins and simulation 
results are expressed by the bound fraction of integrins that remains in 
response to varying the oscillation amplitude. By comparison, the bound 
fraction of integrins is a model-derived parameter and could not be measured 
experimentally with the AFM. Instead, to approximate the integrin bound 
fraction, we used the AFM to directly measure and apply nanoscale force to 
ECM-induced focal adhesion sites. We could also closely approximate bound 
integrin fraction and integrin adhesion state by measuring the bead-cell 
separation distance, which is also predicted by the simulation model. Therefore, 
the peaks in the bead-cell distance, which represents the maximum separation 
between bead and cell during each cycle, was used as measurement of the 
adhesion state. For comparison of model simulation and experimental data, we 
plotted the maximum, mean and minimum cell-bead separation for different 
amplitude oscillations of the simulations model in Figure 3-5A. A high 
separation (seen for high amplitude oscillations) indicates the full rupture state, 
whereas the low separation (seen for low amplitude oscillations) shows there 
some remaining adhesions. Simulations show there is a small window of bi-
stability for intermediate values of  (e.g. =2.425, 2.475). For lower amplitude 
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oscillations (<2.4), the separation between cell and ECM approaches zero. The 
peak bead-cell separation distance of experimental data for full range of 
amplitudes showed in Figure 3-5B. Compared with simulation model, biological 
data showed similar distribution patter that transit point showed around ramp 
sizes of 1000 nm and 1400 nm. 
 
Figure 3-5. The cell-bead separation obtained from all amplitudes for the 
simulation model and biological data. (A) The cell-bead separation of simulation 
model. High separation (seen for high amplitude oscillations) indicates the full 
rupture state, whereas low separation (low amplitude oscillations) shows that 
adhesion dominates. There is a transition window of bistability (e.g., A-2.425, 
2.475). This transition represents the point at which adhesion rupture abruptly 
dominates over adhesion as amplitude is increased. As the amplitude of the 
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oscillations approaches the low level, the separation approach to zero as in the 
low amplitude condition. (B) The cell-bead separation of experimental data. 
Compared with simulation model, data distribution showed similar pattern that 
transit point occurred around ramp size of 1400nm. Blue circle represents initial 
non-prebind condition and red circle represents prebind condition.  
 
 
Figure 3-6. Boxplots of peak bead-cell separation for experimental oscillation 
of 1000 nm, and 2000 nm at 0.1 Hz in non-prebind initial condition. (A) Boxplots 
of peak bad-cell separation for 2000 nm. For this amplitude, all 8 cells have a 
high mean separation, and there is very little variation in this value, indicated 
by the low IQ range. (B) Boxplots of peak bead-cell separation for 1000 nm. For 
this amplitude, the mean bead-cell separation is much lower for all cells.  
 
Figure 3-6 illustrates analysis of 1000 nm and 2000 nm amplitude 
oscillations under non-prebind conditions. The adhesion state was measured 
  70 
by ratio of peak separation distance to amplitude. For experimental data with 
2000 nm oscillations at 0.1Hz, all 8 cells produced similar behavior, with a 
consistently large bead-cell separation at each cycle due to a full rupture of all 
adhesions (Fig. 3-6A). In contrast, for experimental data using 1000 nm 
oscillations at 0.1Hz, the mean bead-cell separation is now much lower for all 
cells (Fig. 3-6B). Therefore, 1000 nm was selected as low amplitude for 
comparison to the simulation model and 2000 nm was used as the high 
amplitude for comparison with the model. The non-prebind and prebind data 
showed similar integrin adhesion behavior as predicted by the model at 
amplitudes of 1000 nm and 2000 nm. For other lower amplitudes, from 200 nm 
to 600 nm, separation of the FN-coated bead from the VSMC was not observed 
(data not shown).  Peak bead-cell separation for experiments of all amplitudes 
from 200 nm to 2000 nm was plotted in Figure 3-7, and mean peak of prebind 
and non-prebind for each amplitude was compared statistically by two-sample 
Kolmogorv-Simirnov test. Mean peak bead-cell separation from amplitude of 
1200 nm is significantly higher in non-pre-bind condition than the one in pre-
bind condition at p level of 0.05. 
Effect of cell compliance and model limitation 
From the simulation model, a unique bistable behavior of integrin 
adhesion during intermediate amplitude displacement is predicted. One 
possibility is that this is due to multiple integrin adhesion cooperativity that in 
the model leads to differences in membrane deformation. With no existing 
integrin adhesion as the starting point there is less membrane deformation as 
the displacement cycle begins and the distance between cell and ECM 
separates quickly and therefore is larger leading to adhesion rupture. With pre-
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existing integrin adhesions, there is a cooperativity and more membrane 
deformation with applied displacement and this distance is reduced. In the 
simulation model, stiffer cells were predicted to have longer separation distance 
of bead-cell at given amplitude, just as shown in Figure 3-8. 
 
Figure 3-7. Boxplots of peak bead-cell separation for all experimental data in 
both non-prebind and prebind (shaded) initial conditions. Experimental data 
was collected from 200 nm to 2000 nm amplitude oscillations. At 1200 nm 
amplitude, mean peak bead-cell separation of non-prebind initial condition is 
significantly higher than that of prebind initial condition (P < 0.05). 
 
The model designed for testing of an integrin focal adhesion interacting 
with the extracellular matrix (ECM) under deformation is a 3-spring model. The 
springs are represented by the vascular smooth muscle cell (VSMC), integirns 
and the ECM and each represented as linear springs with their own spring 
constants. Changes to any of these constants would lead to changes in the 
simulation outcomes and the nature of the bistable behavior. For example, 
VSMC stiffness would alter the level of cell deformation, which would affect the 
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distance between the cell and ECM. For compliant cells, more membrane 
deformation and a reduced distance between cell and ECM would be expected. 
Consequently, there is more integrin bond survival, and higher amplitudes of 
oscillation are needed to induce rupture, in other words the adhesions are more 
stable and can tolerate larger displacements and loads. These results suggest 
that changes in the cell compliance would alter the amplitude at which we see 
the high and low states, and therefore the position of a bistable region. 
However, further experimental work and model development is needed to see 
if stiffer VSMC exhibit changes in the bistable region.   
 
Figure 3-8. Effect of cell compliance on mean peak bead-cell separation 
distance for simulation model. KA represents cell compliance that low KA values 
indicates more compliant cells. For more compliance cells, a larger amplitude, 
A, is needed to induce rupture. Additionally, the separation distance is lower in 
compliant cells due to more cell deformation. 
 
Many cardiovascular diseases are associated with changes in integrin 
expression, extracellular matrix (ECM) stiffness and vascular smooth muscle 
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cell (VSMC) stiffness [30, 84, 131]. Alteration of any of these values significantly 
changes the model predictions and from a pathophysiological point of view 
could significantly affect vascular function. As an example, collective evidence 
from our laboratory has demonstrated that cell stiffness can be correlated with 
integrin adhesion to ECM. VSMCs from normotensive animals that are less stiff 
than cells from hypertensive animals there is less adhesion to ECM whereas 
stiff cells exhibit enhanced cell adhesion to ECM [30]. 
Varying cell stiffness in the present model shows changes in integrin 
adhesion to vertical oscillations in the opposite way. Thus, these experimental 
data suggest there are multiple complexities (e.g. the inclusion of the 
cytoskeleton, which is absent in the model) to consider when trying to 
understand a cell’s behavior to mechanical forces and the adaptations that take 
place. Again, this points to the need for more experimental data and additional 
modeling. Developing a fuller understanding will require continued collaboration 
of scientists from different disciplines. 
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CHAPTER IV 
SUMMARY AND FUTURE DIRECTIONS 
Integrins provide a physical bridge between the cytoskeleton and 
extracellular matrix proteins. This bridge of molecules is constantly exposed to 
mechanical and chemical stimuli from both inside and outside of the cells. 
Therefore, integrin adhesion to ECM must be a dynamically regulated response 
to the cellular microenvironment. In the vascular system, integrins have been 
demonstrated to play an important role in physiological and pathological 
conditions. Thus, investigation into the mechanisms governing adhesion of 
VSMC is important and necessary to achieve a better understanding of 
vascular disease. The work described in this series of studies focused on 
integrin adhesion in response to both chemical and mechanical stimulation.  
The first series of studies describes work focused on trying to clarify 
cellular mechanisms that coordinate integrin adhesion with VSMC 
biomechanical status. This work concentrated on changes in integrin adhesion 
to FN with activation of VSMC to alter the contractile state and alter cell 
stiffness. My work suggests that intracellular Ca2+ involved in this coordination 
of adhesion with contraction/cellular mechanical state. However, mechanisms 
concerning how integrin adhesion was coordinated with cell stiffness are still 
not fully understood. Some areas of future study include investigating the 
specific calcium related signaling pathway or pathways that directly exert their 
effects on integrin adhesion or integrin associated proteins. Though cell 
stiffness is believed to be mostly governed by myosin-generated contractility, 
which is known to be regulated by intracellular level of Ca2+, cytoskeleton 
remodeling also occurs in VSMCs following AII and cell contractile activation. 
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This suggest actin polymerization/depolymerizaton processes are an important 
area for future study and for further examining a role for Ca2+. There are several 
good candidates that could be studied to determine role of actin remodeling in 
acute changes in stiffness following VSMC stimulation. One is calcium-
calmodulin-dependent protein kinase II (CaMKII) that has been reported to 
regulate actin cytoskeletal assembly [116]. Additionally, actin polymerization is 
reported to be mediated through other pathways, such as RhoA. In relation to 
my studies, RhoA is also reported to be activated by AII [57]. Taken together 
with the fact that integrin engagement with the ECM also results in the activation 
of a vast spectrum of signaling pathways including small GTPase of the Rho 
family [63, 86] make this possibility attractive. Thus, it is clear that further 
studies would be needed to fully elucidate the precise signaling mechanism or 
mechanisms governing regulation of cellular mechanics and cell adhesion. To 
test possible involvement of RhoA/Rho kinase signaling pathway in AII-induced 
integrin activation, it is proposed that measurement of the active form of RhoA 
and total RhoA by western blotting after AII treatment. Possible RhoA targeted 
phosphorylated proteins would also be measured by western blotting. Another 
powerful approach would be to modulate expression of specific molecules, like 
RhoA, by overexpression or knockdown using shRNA. This would be a useful 
approach to identify whether changes in adhesion would be enhanced or 
suppressed.  
In the second series studies conducted as part of this dissertation, my 
work focused on integrin adhesion responses to imposed mechanical 
oscillations. This study evolved out of a collaboration with Dr. Bindi Brook at the 
Department of Mathematical Sciences, University of Nottingham. As part of the 
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study, Dr. Brook and colleagues designed a mathematical model to describe 
the behavior of integrins in a focal adhesion during exposure to oscillatory 
mechanical force or stretch, such as might occur with pulse pressure. The 
model predicted unique integrin behavior emerging from the pattern of 
adhesion as the level of force or stretch on the adhesion was changed. This 
unique pattern was called ‘bistability”. In order to test these model predictions, 
my studies were designed to mimic the model simulations and collect actual 
biological data to either confirm or inform the model so it could be improved. 
Vertical oscillations were applied using AFM to test integrin adhesion behavior 
proposed in the mathematical simulation model. The results indicated that 
integrin behavior did display significant changes based on the initial state of 
integrin adhesion to the ECM and oscillation amplitudes (i.e. force/stretch). 
Since these simulations and experiments were conducted in the vertical 
direction and an important future direction is to explore integrin adhesion 
behavior when integrin adhesions are exposed to shearing or lateral force and 
stretch. VSMCs sense force not only vertically but also laterally so this is a 
physiologically relevant future direction for additional studies.  How integrin 
adhesions in VSMC would respond to lateral oscillations has not yet been 
studied. Lateral oscillations can be performed by lateral force microscopy 
(LFM), which is also called friction force microscopy (FFM) and represents 
another operation mode in a standard AFM instrument working in contact mode 
[132]. In LFM, the cantilever is moved laterally over the investigated surface, 
and in this case, the interaction forces cause cantilever torsion, then the 
magnitude of the interaction forces can be determined by obtaining the force 
curves for torsion. Therefore, protocols performed in LFM are completely 
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different from normal AFM experiments, including calibration of cantilever, 
collecting and processing data. For LFM, the lateral force was determined by 
multiplying the recorded signal by the torsional spring constant and lateral 
photodetector sensitivity. Both parameters are difficult to estimate using 
traditional methods. To date, we have tried calibration of torsional spring 
constant with Sader methods [133, 134]. More work on collecting, analyzing 
and processing lateral data would be needed to complete lateral experiments. 
Additionally, the proposed simulation model simply takes a whole cell as 
a spring that is constant throughout a simulation. However, cell membrane and 
cytoskeleton networks have different compliances and showed different 
behavior response to applied force that should not be considered as one spring. 
Thus, future refinement of the model should include more variables and 
parameters to represent these cellular constituents. Improvements such as this 
would likely improve the accuracy of the predictions and usefulness of the 
model. Moreover, in biological conditions, collective evidence has 
demonstrated cell stiffness changed the response to the dynamic 
microenvironment, including integrin activation and the bistable point. This may 
have significant implications in pathology where ECM and cell thickness have 
increased with consequential effects on signaling and vessel behavior.  
It is of interest that the simulation model predicts a loss of focal adhesion 
stability as VSMC stiffness is enhanced. This has pathophysiological 
implications to hypertension and aging where VSMC stiffness is increased and 
suggest that these diseases may destabilize the focal adhesion and lead to a 
cycle of adaptive changes that lead to alteration in the ECM as well as adhesion 
molecule expression. In the simulation model Integrin expression is assumed 
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to remain constant. However, the literature reports that in chronic hypertension 
and aging that adhesion molecule expression is upregulated. It is reasonable 
to speculate the changes in expression may be a cellular mechanism to attempt 
to stabilize the focal adhesion so it will function normally. Thus, our simulation 
model informed on additional biological detail could be further refined to more 
accurately reflect the biological elements.  
Besides adhesion of VSMC integrins to ECM proteins, cell-cell adhesion, 
mediated by cadherins, is also known important to maintain tissue structure and 
reported to regulate cellular signaling [135]. Therefore, future work would to 
study cell-cell adhesion responses to both vertical or lateral oscillations is also 
anticipated to yield important information relevant to VSMC behavior in the 
vascular wall. Moreover, there have been intracellular crosslinks identified 
between cadherin-mediated cell-cell adhesions and integrin-mediated cell-
ECM adhesion that are important in signaling and integrating responses to 
mechanical forces [136]. In this case, building a new model to effect cadherin 
adhesion on integrin adhesion or vice versa would be necessary to help us 
understand the full picture of VSMCs adhesion behavior.  
It is of interest that although the signaling role of integrins has been 
investigated extensively following integrin engagement or binding with ECM, 
there have been no studies to date that have focused on cellular signaling 
responses that might be entirely unique to rupture an integrin adhesion when it 
separates from an ECM binding site. The observed ‘bistable” behavior reported 
in this study suggest this would be a very novel and perhaps fruitful direction 
for future study. Since integrins are known to undergo dynamic regulation that 
includes spatial rearrangement on the cell surface recruitment to focal 
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adhesions [17], in this reverse process, integrin rupture could activate separate 
signal pathways in addition to turning off the classical out-side in pathways.  
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